Reference |
21539
Deborah E Daniels, Damien J Downes, Ivan Ferrer-Vicens, Daniel C J Ferguson, Belinda K Singleton, Marieangela C Wilson, Kongtana Trakarnsanga, Ryo Kurita, Yukio Nakamura, David J Anstee, Jan Frayne
Erratum to: Comparing the two leading erythroid lines BEL-A and HUDEP-2
Haematologica
2024
Jan 1;109(1):364
PubMed ID: 38186343
DOI: 10.3324/haematol.2023.284510
|
21906
Thijs C. J. Verheul, Nynke Gillemans, Kerstin Putzker, Rezin Majied, Tingyue Li, Memnia Vasiliou, Bert Eussen, Annelies de Klein, Wilfred F. J. van IJcken, Emile van den Akker, Marieke von Lindern, Joe Lewis, Ulrike Uhrig, Yukio Nakamura, Thamar van Dijk, Sjaak Philipsen
A cellular reporter system to evaluate endogenous fetal hemoglobin induction and screen for therapeutic compounds
Hemasphere
2024
Aug 6;8(8):e139
PubMed ID: 39108322
DOI: 10.1002/hem3.139
|
18128
Papaioannou NY, Patsali P, Naiisseh B, Papasavva PL, Koniali L, Kurita R, Nakamura Y, Christou S, Sitarou M, Mussolino C, Cathomen T, Kleanthous M, Lederer CW.
High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on in vitro mRNA synthesis
Front Genome Ed
2023
5:1141618
PubMed ID: 36969374
DOI: 10.3389/fgeed.2023.1141618
|
18359
Venkatesan V, Christopher AC, Rhiel M, Azhagiri MKK, Babu P, Walavalkar K, Saravanan B, Andrieux G, Rangaraj S, Srinivasan S, Karuppusamy KV, Jacob A, Bagchi A, Pai AA, Nakamura Y, Kurita R, Balasubramanian P, Pai R, Marepally SK, Mohankumar KM, Velayudhan SR, Boerries M, Notani D, Cathomen T, Srivastava A, Thangavel S.
Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathies
Mol Ther Nucleic Acids
2023
32:671-688
PubMed ID: 37215154
DOI: 10.1016/j.omtn.2023.04.024
|
18360
Lv X, Murphy K, Murphy Z, Getman MR, Rahman NF, Nakamura Y, Blanc L, Gallagher PG, Palis J, Mohandas N, Steiner LA.
HEXIM1 is an Essential Transcription Regulator During Human Erythropoiesis
Blood
2023
blood.2022019495
PubMed ID: 37738561
DOI: 10.1182/blood.2022019495
|
18441
Zhang X, Xia F, Zhang X, Blumenthal RM, Cheng X.
C2H2 zinc finger transcription factors associated with hemoglobinopathies
J Mol Biol
2023
168343
PubMed ID: 37924864
DOI: 10.1016/j.jmb.2023.168343
|
18495
Lu HY, Orkin SH, Sankaran VG.
Fetal Hemoglobin Regulation in Beta-Thalassemia
Hematol Oncol Clin North Am
2023
37(2):301-312
PubMed ID: 36907604
DOI: 10.1016/j.hoc.2022.12.002
|
18497
Zeng S, Lei S, Qu C, Wang Y, Teng S, Huang P.
CRISPR/Cas-based gene editing in therapeutic strategies for beta-thalassemia
Hum Genet
2023
Oct 25
PubMed ID: 37878144
DOI: 10.1007/s00439-023-02610-9
|
18508
Arif T, Farooq A, Ahmad FJ, Akhtar M, Choudhery MS.
Prime editing: A potential treatment option for β-thalassemia
Cell Biol Int
2023
47(4):699-713
PubMed ID: 36480796
DOI: 10.1002/cbin.11972
|
18512
Li J, Lv A, Chen M, Xu L, Huang H.
Activating transcription factor 4 in erythroid development and [Formula: see text]-thalassemia: a powerful regulator with therapeutic potential
Ann Hematol
2023
Oct 31
PubMed ID: 37906269
DOI: 10.1007/s00277-023-05508-8
|
18513
Shen F, Dassama LMK.
Opportunities and challenges of protein-based targeted protein degradation
Chem Sci
2023
14(32):8433-8447
PubMed ID: 37592990
DOI: 10.1039/d3sc02361c
|
18520
Ma L, Yang S, Peng Q, Zhang J, Zhang J.
CRISPR/Cas9-based gene-editing technology for sickle cell disease
Gene
2023
874:147480
PubMed ID: 37182559
DOI: 10.1016/j.gene.2023.147480
|
18522
Khiabani A, Kohansal MH, Keshavarzi A, Shahraki H, Kooshesh M, Karimzade M, Gholizadeh Navashenaq J.
CRISPR/Cas9, a promising approach for the treatment of β-thalassemia: a systematic review
Mol Genet Genomics
2023
298(1):1-11
PubMed ID: 36403178
DOI: 10.1007/s00438-022-01978-z
|
18527
Kargutkar N, Hariharan P, Nadkarni A.
Dynamic interplay of microRNA in diseases and therapeutic
Clin Genet
2023
103(3):268-276
PubMed ID: 36310341
DOI: 10.1111/cge.14256
|
18528
Paschoudi K, Yannaki E, Psatha N.
Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies
Int J Mol Sci
2023
24(11):9527
PubMed ID: 37298481
DOI: 10.3390/ijms24119527
|
18540
Kraus C, Sontheimer EJ.
Applications of Anti-CRISPR Proteins in Genome Editing and Biotechnology
J Mol Biol
2023
435(13):168120
PubMed ID: 37100169
DOI: 10.1016/j.jmb.2023.168120
|
18544
Sahu S, Poplawska M, Lim SH, Dutta D.
CRISPR-based precision medicine for hematologic disorders: Advancements, challenges, and prospects
Life Sci
2023
333:122165
PubMed ID: 37832631
DOI: 10.1016/j.lfs.2023.122165
|
18545
Voloshin N, Tyurin-Kuzmin P, Karagyaur M, Akopyan Z, Kulebyakin K.
Practical Use of Immortalized Cells in Medicine: Current Advances and Future Perspectives
Int J Mol Sci
2023
24(16):12716
PubMed ID: 37628897
DOI: 10.3390/ijms241612716
|
18546
Finotti A, Gambari R.
Combined approaches for increasing fetal hemoglobin (HbF) and de novo production of adult hemoglobin (HbA) in erythroid cells from β-thalassemia patients: treatment with HbF inducers and CRISPR-Cas9 based genome editing
Front Genome Ed
2023
5:1204536
PubMed ID: 37529398
DOI: 10.3389/fgeed.2023.1204536
|
18547
Lu X, Zhang M, Li G, Zhang S, Zhang J, Fu X, Sun F.
Applications and Research Advances in the Delivery of CRISPR/Cas9 Systems for the Treatment of Inherited Diseases
Int J Mol Sci
2023
24(17):13202
PubMed ID: 37686009
DOI: 10.3390/ijms241713202
|
18548
Weiner L, Brissette JL.
Finding meaning in chaos: a selection signature for functional interactions and its use in molecular biology
FEBS J
2023
290(16):3914-3927.
PubMed ID: 35653424
DOI: 10.1111/febs.16542
|
17392
Takase S, Hiroyama T, Shirai F, Maemoto Y, Nakata A, Arata M, Matsuoka S, Sonoda T, Niwa H, Sato S, Umehara T, Shirouzu M, Nishigaya Y, Sumiya T, Hashimoto N, Namie R, Usui M, Ohishi T, Ohba SI, Kawada M, Hayashi Y, Harada H, Yamaguchi T, Shinkai Y, Nakamura Y, Yoshida M, Ito A.
A specific G9a inhibitor unveils BGLT3 lncRNA as a universal mediator of chemically induced fetal globin gene expression
Nat Commun
2023
14(1):23.
PubMed ID: 36635268
DOI: 10.1038/s41467-022-35404-0
|
17721
Soboleva S, Kurita R, Kajitani N, Åkerstrand H, Miharada K.
Establishment of an immortalized human erythroid cell line sustaining differentiation potential without inducible gene expression system
Hum Cell
2022
35(1):408-417
PubMed ID: 34817797
DOI: 10.1007/s13577-021-00652-7
|
18352
Dulmovits BM, Tang Y, Papoin J, He M, Li J, Yang H, Addorisio ME, Kennedy L, Khan M, Brindley E, Ashley RJ, Ackert-Bicknell C, Hale J, Kurita R, Nakamura Y, Diamond B, Barnes BJ, Hermine O, Gallagher PG, Steiner LA, Lipton JM, Taylor N, Mohandas N, Andersson U, Al-Abed Y, Tracey KJ, Blanc L.
HMGB1-mediated restriction of EPO signaling contributes to anemia of inflammation
Blood
2022
139(21):3181-3193.
PubMed ID: 35040907
DOI: 10.1182/blood.2021012048
|
18353
Ravi NS, Wienert B, Wyman SK, Bell HW, George A, Mahalingam G, Vu JT, Prasad K, Bandlamudi BP, Devaraju N, Rajendiran V, Syedbasha N, Pai AA, Nakamura Y, Kurita R, Narayanasamy M, Balasubramanian P, Thangavel S, Marepally S, Velayudhan SR, Srivastava A, DeWitt MA, Crossley M, Corn JE, Mohankumar KM.
Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin
Elife
2022
11:e65421
PubMed ID: 35147495
DOI: 10.7554/eLife.65421
|
18354
Wang B, Wang C, Wan Y, Gao J, Ma Y, Zhang Y, Tong J, Zhang Y, Liu J, Chang L, Xu C, Shen B, Chen Y, Jiang E, Kurita R, Nakamura Y, Lim KC, Engel JD, Zhou J, Cheng T, Zhu X, Zhu P, Shi L.
Decoding the pathogenesis of Diamond-Blackfan anemia using single-cell RNA-seq
Cell Discov
2022
8(1):41
PubMed ID: 35534476
DOI: 10.1038/s41421-022-00389-z
|
18355
Lu D, Xu Z, Peng Z, Yang Y, Song B, Xiong Z, Ma Z, Guan H, Chen B, Nakamura Y, Zeng J, Liu N, Sun X, Chen D.
Induction of Fetal Hemoglobin by Introducing Natural Hereditary Persistence of Fetal Hemoglobin Mutations in the γ-Globin Gene Promoters for Genome Editing Therapies for β-Thalassemia
Front Genet
2022
13:881937.
PubMed ID: 35656314
DOI: 10.3389/fgene.2022.881937
|
18356
Bagchi A, Devaraju N, Chambayil K, Rajendiran V, Venkatesan V, Sayed N, Pai AA, Nath A, David E, Nakamura Y, Balasubramanian P, Srivastava A, Thangavel S, Mohankumar KM, Velayudhan SR.
Erythroid lineage-specific lentiviral RNAi vectors suitable for molecular functional studies and therapeutic applications
Sci Rep
2022
12(1):14033
PubMed ID: 35982069
DOI: 10.1038/s41598-022-13783-0
|
18357
Ochi T, Fujiwara T, Ono K, Suzuki C, Nikaido M, Inoue D, Kato H, Onodera K, Ichikawa S, Fukuhara N, Onishi Y, Yokoyama H, Nakamura Y, Harigae H.
Exploring the mechanistic link between SF3B1 mutation and ring sideroblast formation in myelodysplastic syndrome
Sci Rep
2022
12(1):14562
PubMed ID: 36028755
DOI: 10.1038/s41598-022-18921-2
|
18366
Koya Ono, Tohru Fujiwara, Hiroki Shima, Hironari Nishizawa, Chie Suzuki, Noriyuki Takahashi, Hiroki Kato, Koichi Onodera, Satoshi Ichikawa, Noriko Fukuhara, Yasushi Onishi, Hisayuki Yokoyama, Yukio Nakamura, Kazuhiko Igarashi, Hideo Harigae
Altered Transcription By GATA1 Impairs Autophagy and Prevents Ferroptosis in X-Linked Sideroblastic Anemia
Blood
2022
140:2467-2468
DOI: 10.1182/blood-2022-163073
|
18372
King R, Gallagher PJ, Khoriaty R.
The congenital dyserythropoieitic anemias: genetics and pathophysiology
Curr Opin Hematol
2022
29(3):126-136
PubMed ID: 35441598
DOI: 10.1097/MOH.0000000000000697
|
18385
Han Y, Tan X, Jin T, Zhao S, Hu L, Zhang W, Kurita R, Nakamura Y, Liu J, Li D, Zhang Z, Fang X, Huang S.
CRISPR/Cas9-based multiplex genome editing of BCL11A and HBG efficiently induces fetal hemoglobin expression
Eur J Pharmacol
2022
918:174788
PubMed ID: 35093321
DOI: 10.1016/j.ejphar.2022.174788
|
18401
Eccleston A.
HIF1α reboots fetal haemoglobin production
Nat Rev Drug Discov
2022
21(12):878
PubMed ID: 36307651
DOI: 10.1038/d41573-022-00179-y
|
18494
Feldman TP, Egan ES.
Uncovering a Cryptic Site of Malaria Pathogenesis: Models to Study Interactions Between Plasmodium and the Bone Marrow
Front Cell Infect Microbiol
2022
12:917267
PubMed ID: 35719356
DOI: 10.3389/fcimb.2022.917267
|
18517
Mukherjee M, Rahaman M, Ray SK, Shukla PC, Dolai TK, Chakravorty N.
Revisiting fetal hemoglobin inducers in beta-hemoglobinopathies: a review of natural products, conventional and combinatorial therapies
Mol Biol Rep
2022
49(3):2359-2373
PubMed ID: 34822068
DOI: 10.1007/s11033-021-06977-8
|
18523
Tetard M, Peterson NA, Egan ES.
Erythrocyte-Plasmodium interactions: genetic manipulation of the erythroid lineage
Curr Opin Microbiol
2022
70:102221
PubMed ID: 36242898
DOI: 10.1016/j.mib.2022.102221
|
18525
Boutin J, Cappellen D, Rosier J, Amintas S, Dabernat S, Bedel A, Moreau-Gaudry F.
ON-Target Adverse Events of CRISPR-Cas9 Nuclease: More Chaotic than Expected
CRISPR J
2022
5(1):19-30
PubMed ID: 35099280
DOI: 10.1089/crispr.2021.0120
|
18529
Chauhan W, Shoaib S, Fatma R, Zaka-Ur-Rab Z, Afzal M.
Beta-thalassemia and the advent of new interventions beyond transfusion and iron chelation
Br J Clin Pharmacol
2022
88(8):3610-3626
PubMed ID: 35373382
DOI: 10.1111/bcp.15343
|
18531
Reshetnikov VV, Chirinskaite AV, Sopova JV, Ivanov RA, Leonova EI.
Translational potential of base-editing tools for gene therapy of monogenic diseases
Front Bioeng Biotechnol
2022
10:942440
PubMed ID: 36032737
DOI: 10.3389/fbioe.2022.942440
|
18532
Ding J, Frantzeskos A, Orozco G.
Functional interrogation of autoimmune disease genetics using CRISPR/Cas9 technologies and massively parallel reporter assays
Semin Immunopathol
2022
44(1):137-147
PubMed ID: 34508276
DOI: 10.1007/s00281-021-00887-4
|
18535
Germino-Watnick P, Hinds M, Le A, Chu R, Liu X, Uchida N.
Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease
Cells
2022
11(11):1843
PubMed ID: 35681538
DOI: 10.3390/cells11111843
|
18538
Taha EA, Lee J, Hotta A.
Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges
J Control Release
2022
342:345-361
PubMed ID: 35026352
DOI: 10.1016/j.jconrel.2022.01.013
|
18541
Rahimmanesh I, Boshtam M, Kouhpayeh S, Khanahmad H, Dabiri A, Ahangarzadeh S, Esmaeili Y, Bidram E, Vaseghi G, Haghjooy Javanmard S, Shariati L, Zarrabi A, Varma RS.
Gene Editing-Based Technologies for Beta-hemoglobinopathies Treatment
Biology (Basel)
2022
11(6):862
PubMed ID: 35741383
DOI: 10.3390/biology11060862
|
18543
Li Z, Zhou P, Kwon E, Fitzgerald KA, Weng Z, Zhou C.
Flnc: Machine Learning Improves the Identification of Novel Long Noncoding RNAs from Stand-Alone RNA-Seq Data
Noncoding RNA
2022
8(5):70
PubMed ID: 36287122
DOI: 10.3390/ncrna8050070
|
13945
Papasavva PL, Patsali P, Loucari CC, Kurita R, Nakamura Y, Kleanthous M, Lederer CW.
CRISPR Editing Enables Consequential Tag-Activated MicroRNA-Mediated Endogene Deactivation
Int J Mol Sci
2022
23(3):1082
PubMed ID: 35163006
DOI: 10.3390/ijms23031082
|
20678
Ono K, Fujiwara T, Saito K, Nishizawa H, Takahashi N, Suzuki C, Ochi T, Kato H, Ishii Y, Onodera K, Ichikawa S, Fukuhara N, Onishi Y, Yokoyama H, Yamada R, Nakamura Y, Igarashi K, Harigae H.
Congenital sideroblastic anemia model due to ALAS2 mutation is susceptible to ferroptosis.
Sci Rep
2022
12(1):9024
PubMed ID: 35637209
DOI: 10.1038/s41598-022-12940-9
|
20811
Tingting Jin, Zhaojun Zhang, Yuanyuan Han, Di Li, Juan Liu, Minmin Jiang, Junwei Zhu, Ryo Kurita, Yukio Nakamura, Fangfang Hu, Yongjie Xu, Xiangdong Fang, Shengwen Huang , and Zhaolin Sun
Transmembrane Protein ANTXR1 Regulates γ-Globin Expression by Targeting the Wnt/ β-Catenin Signaling Pathway.
Journal of Immunology Research
2022
PubMed ID: 35942209
DOI: 10.1155/2022/8440422
|
20830
Tingting Jin, Zhaojun Zhang, Yuanyuan Han, Di Li, Juan Liu, Minmin Jiang, Ryo Kurita, Yukio Nakamura, Fangfang Hu, Xiangdong Fang, Shengwen Huang, and Zhaolin Sun
ANTXR1 Regulates Erythroid Cell Proliferation and Differentiation through wnt/β-Catenin Signaling Pathway In Vitro and in Hematopoietic Stem Cell
Disease Markers
2022
15
PubMed ID: 36065334
DOI: 10.1155/2022/1226697
|
17722
Soboleva S, Kurita R, Ek F, Åkerstrand H, Silvério-Alves R, Olsson R, Nakamura Y, Miharada K.
Identification of potential chemical compounds enhancing generation of enucleated cells from immortalized human erythroid cell lines
Commun Biol
2021
4(1):677
PubMed ID: 34083702
DOI: 10.1038/s42003-021-02202-1
|
18339
Mingoia M, Caria CA, Ye L, Asunis I, Marongiu MF, Manunza L, Sollaino MC, Wang J, Cabriolu A, Kurita R, Nakamura Y, Cucca F, Kan YW, Marini MG, Moi P.
Induction of therapeutic levels of HbF in genome-edited primary β0 39-thalassaemia haematopoietic stem and progenitor cells
Br J Haematol
2021
192(2):395-404
PubMed ID: 33216968
DOI: 10.1111/bjh.17167
|
18340
Ishii S, Suzuki T, Wakahashi K, Asada N, Kawano Y, Kawano H, Sada A, Minagawa K, Nakamura Y, Mizuno S, Takahashi S, Matsui T, Katayama Y. タイトル
FGF-23 from erythroblasts promotes hematopoietic progenitor mobilization
Blood
2021
137(11):1457-1467
PubMed ID: 33512467
DOI: 10.1182/blood.2020007172
|
18341
Breda L, Ghiaccio V, Tanaka N, Jarocha D, Ikawa Y, Abdulmalik O, Dong A, Casu C, Raabe TD, Shan X, Danet-Desnoyers GA, Doto AM, Everett J, Bushman FD, Radaelli E, Assenmacher CA, Tarrant JC, Hoepp N, Kurita R, Nakamura Y, Guzikowski V, Smith-Whitley K, Kwiatkowski JL, Rivella S.
Lentiviral vector ALS20 yields high hemoglobin levels with low genomic integrations for treatment of beta-globinopathies
Mol Ther . 2021 Apr 7;29(4):1625-1638
2021
Mol Ther . 2021 Apr 7;29(4):1625-1638
PubMed ID: 33515514
DOI: 10.1016/j.ymthe.2020.12.036
|
18342
Bao X, Zhang X, Wang L, Wang Z, Huang J, Zhang Q, Ye Y, Liu Y, Chen D, Zuo Y, Liu Q, Xu P, Huang B, Fang J, Lao J, Feng X, Li Y, Kurita R, Nakamura Y, Yu W, Ju C, Huang C, Mohandas N, Li D, Zhao C, Xu X.
Epigenetic inactivation of ERF reactivates γ-globin expression in β-thalassemia
Am J Hum Genet
2021
108(4):709-721
PubMed ID: 33735615
DOI: 10.1016/j.ajhg.2021.03.005
|
18343
Bagchi A, Nath A, Thamodaran V, Ijee S, Palani D, Rajendiran V, Venkatesan V, Datari P, Pai AA, Janet NB, Balasubramanian P, Nakamura Y, Srivastava A, Mohankumar KM, Thangavel S, Velayudhan SR.
Direct Generation of Immortalized Erythroid Progenitor Cell Lines from Peripheral Blood Mononuclear Cells
Cells
2021
10(3):523.
PubMed ID: 33804564
DOI: 10.3390/cells10030523
|
18344
Liang Y, Zhang X, Liu Y, Wang L, Ye Y, Tan X, Pu J, Zhang Q, Bao X, Wei X, Li D, Kurita R, Nakamura Y, Li D, Xu X.
GATA zinc finger domain-containing protein 2A (GATAD2A) deficiency reactivates fetal haemoglobin in patients with β-thalassaemia through impaired formation of methyl-binding domain protein 2 (MBD2)-containing nucleosome remodelling and deacetylation (NuRD) complex
Br J Haematol
2021
193(6):1220-1227
PubMed ID: 33997955
DOI: 10.1111/bjh.17511
|
18345
Pires Lourenco S, Jarocha D, Ghiaccio V, Guerra A, Abdulmalik O, La P, Zezulin A, Smith-Whitley K, Kwiatkowski JL, Guzikowski V, Nakamura Y, Raabe T, Breda L, Rivella S.
Inclusion of a short hairpin RNA targeting BCL11A into a β-globin expressing vector allows concurrent synthesis of curative adult and fetal hemoglobin
Haematologica
2021
106(10):2740-2745
PubMed ID: 34047176
DOI: 10.3324/haematol.2020.276634
|
18346
Jeffery NN, Davidson C, Peslak SA, Kingsley PD, Nakamura Y, Palis J, Bulger M.
Histone H2A.X phosphorylation and Caspase-Initiated Chromatin Condensation in late-stage erythropoiesis
Epigenetics Chromatin
2021
14(1):37.
PubMed ID: 34330317
DOI: 10.1186/s13072-021-00408-5
|
18347
Li X, Chen M, Liu B, Lu P, Lv X, Zhao X, Cui S, Xu P, Nakamura Y, Kurita R, Chen B, Huang DCS, Liu DP, Liu M, Zhao Q.
Transcriptional silencing of fetal hemoglobin expression by NonO
Nucleic Acids Res
2021
49(17):9711-9723.
PubMed ID: 34379783
DOI: 10.1093/nar/gkab671
|
18348
Daniels DE, Ferguson DCJ, Griffiths RE, Trakarnsanga K, Cogan N, MacInnes KA, Mordue KE, Andrienko T, Ferrer-Vicens I, Ramos Jiménez D, Lewis PA, Wilson MC, Canham MA, Kurita R, Nakamura Y, Anstee DJ, Frayne J.
Reproducible immortalization of erythroblasts from multiple stem cell sources provides approach for sustainable RBC therapeutics
Mol Ther Methods Clin Dev
2021
22:26-39
PubMed ID: 34485592
DOI: 10.1016/j.omtm.2021.06.002
|
18349
Himadewi P, Wang XQD, Feng F, Gore H, Liu Y, Yu L, Kurita R, Nakamura Y, Pfeifer GP, Liu J, Zhang X.
3'HS1 CTCF binding site in human β-globin locus regulates fetal hemoglobin expression
Elife
2021
10:e70557
PubMed ID: 34585664
DOI: 10.7554/eLife.70557
|
18351
Nath A, Rayabaram J, Ijee S, Bagchi A, Chaudhury AD, Roy D, Chambayil K, Singh J, Nakamura Y, Velayudhan SR.
Comprehensive Analysis of microRNAs in Human Adult Erythropoiesis
Cells
2021
10(11):3018
PubMed ID: 34831239
DOI: 10.3390/cells10113018
|
18398
Tumburu L, Thein SL.
Targeting ZNF410 as a potential β-hemoglobinopathy therapy
Nat Genet
2021
53(5):589-590
PubMed ID: 33859418
DOI: 10.1038/s41588-021-00817-y
|
18430
Cruz LJ, van Dijk T, Vepris O, Li TMWY, Schomann T, Baldazzi F, Kurita R, Nakamura Y, Grosveld F, Philipsen S, Eich C.
PLGA-Nanoparticles for Intracellular Delivery of the CRISPR-Complex to Elevate Fetal Globin Expression in Erythroid Cells
Biomaterials
2021
268:120580
PubMed ID: 33321292
DOI: 10.1016/j.biomaterials.2020.120580
|
18503
Demirci S, Leonard A, Essawi K, Tisdale JF.
CRISPR-Cas9 to induce fetal hemoglobin for the treatment of sickle cell disease
Mol Ther Methods Clin Dev
2021
23:276-285.
PubMed ID: 34729375
DOI: 10.1016/j.omtm.2021.09.010
|
18516
Rao S, Yao Y, Bauer DE.
Editing GWAS: experimental approaches to dissect and exploit disease-associated genetic variation
Genome Med
2021
13(1):41
PubMed ID: 33691767
DOI: 10.1186/s13073-021-00857-3
|
18521
Frati G, Miccio A.
Genome Editing for β-Hemoglobinopathies: Advances and Challenges
J Clin Med
2021
10(3):482.
PubMed ID: 33525591
DOI: 10.3390/jcm10030482
|
18524
Mettananda S.
Genetic and Epigenetic Therapies for β-Thalassaemia by Altering the Expression of α-Globin Gene
Front Genome Ed
2021
3:752278
PubMed ID: 34713267
DOI: 10.3389/fgeed.2021.752278
|
18526
Azhagiri MKK, Babu P, Venkatesan V, Thangavel S.
Homology-directed gene-editing approaches for hematopoietic stem and progenitor cell gene therapy
Stem Cell Res Ther
2021
12(1):500
PubMed ID: 34503562
DOI: 10.1186/s13287-021-02565-6
|
18533
Sharif SB, Zamani N, Chadwick BP.
BAZ1B the Protean Protein
Genes (Basel)
2021
;12(10):1541
PubMed ID: 34680936
DOI: 10.3390/genes12101541
|
18539
Hariharan P, Nadkarni A.
Insight of fetal to adult hemoglobin switch: Genetic modulators and therapeutic targets
Blood Rev
2021
49:100823
PubMed ID: 33726930
DOI: 10.1016/j.blre.2021.100823
|
20087
Ma Y, Liu S, Gao J, Chen C, Zhang X, Yuan H, Chen Z, Yin X, Sun C, Mao Y, Zhou F, Shao Y, Liu Q, Xu J, Cheng L, Yu D, Li P, Yi P, He J, Geng G, Guo Q, Si Y, Zhao H, Li H, Banes GL, Liu H, Nakamura Y, Kurita R, Huang Y, Wang X, Wang F, Fang G, Engel JD, Shi L, Zhang YE, Yu J.
Genome-wide analysis of pseudogenes reveals HBBP1's human-specific essentiality in erythropoiesis and implication in β-thalassemia.
Dev Cell
2021
56(4):478-493.e11
PubMed ID: 33476555
DOI: 10.1016/j.devcel.2020.12.019
|
20294
Ma SP, Xi HR, Gao XX, Yang JM, Kurita R, Nakamura Y, Song XM, Chen HY, Lu DR.
Long noncoding RNA HBBP1 enhances γ-globin expression through the ETS transcription factor ELK1.
Biochem Biophys Res Commun
2021
552:157-163
PubMed ID: 33744764
DOI: 10.1016/j.bbrc.2021.03.051
|
15517
Papasavva PL, Papaioannou NY, Patsali P, Kurita R, Nakamura Y, Sitarou M, Christou S, Kleanthous M, Lederer CW.
Distinct miRNA Signatures and Networks Discern Fetal from Adult Erythroid Differentiation and Primary from Immortalized Erythroid Cells
Int J Mol Sci
2021
22(7):3626.
PubMed ID: 33807258
DOI: 10.3390/ijms22073626
|
15638
King R, Lin Z, Balbin-Cuesta G, Myers G, Friedman A, Zhu G, McGee B, Saunders TL, Kurita R, Nakamura Y, Engel JD, Reddy P, Khoriaty R.
SEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type II
Sci Adv
2021
7(48):eabj5293
PubMed ID: 34818036
DOI: 10.1126/sciadv.abj5293
|
16042
Yannis Hara, Dipti Gupta, Courtney Mercadante, Kim Alving, Yukio Nakamura, Sriram Krishnamoorthy, Alexandra Hicks, Melanie Demers
Heme-Regulated eIF2α Kinase (HRI) Inhibition Decreases PKR Activation in HUDEP2 Cells
Blood
2021
138:2035-2035
DOI: 10.1182/blood-2021-144679
|
16066
Wessels MW, Cnossen MH, van Dijk TB, Gillemans N, Schmidt KLJ, van Lom K, Vinjamur DS, Coyne S, Kurita R, Nakamura Y, de Man SA, Pfundt R, Azmani Z, Brouwer RWW, Bauer DE, van den Hout MCGN, van IJcken WFJ, Philipsen S.
Molecular analysis of the erythroid phenotype of a patient with BCL11A haploinsufficiency
Blood Adv
2021
5(9):2339-2349
PubMed ID: 33938942
DOI: 10.1182/bloodadvances.2020003753
|
18338
Zhang X, Zhu B, Chen L, Xie L, Yu W, Wang Y, Li L, Yin S, Yang L, Hu H, Han H, Li Y, Wang L, Chen G, Ma X, Geng H, Huang W, Pang X, Yang Z, Wu Y, Siwko S, Kurita R, Nakamura Y, Yang L, Liu M, Li D.
Dual base editor catalyzes both cytosine and adenine base conversions in human cells
Nat Biotechnol
2020
38(7):856-860
PubMed ID: 32483363
DOI: 10.1038/s41587-020-0527-y
|
18364
Dipti Gupta, Samuel Lessard, Shujia Dai, Yukio Nakamura, Alexandra Hicks, Thomas K Harris, Sriram Krishnamoorthy
Genetic Silencing of KEAP1 Induces NRF2 Mediated Oxidative Stress Pathway in Human Erythroid Cells
Blood
2020
136:8-9
DOI: 10.1182/blood-2020-139730
|
18365
Dipti Gupta, Yannis Hara, Samuel Lessard, Sarah Sturtevant, Yukio Nakamura, Sriram Krishnamoorthy, Melanie Demers, Alexandra Hicks
Catalytic Activity of Heme-Regulated eIF2 Alpha Kinase (HRI) Regulates Fetal Hemoglobin
Blood
2020
136:7-7
DOI: 10.1182/blood-2020-139991
|
18445
Trakarnsanga K, Tipgomut C, Metheetrairut C, Wattanapanitch M, Khuhapinant A, Poldee S, Kurita R, Nakamura Y, Srisawat C, Frayne J.
Generation of an immortalised erythroid cell line from haematopoietic stem cells of a haemoglobin E/β-thalassemia patient
Sci Rep
2020
10(1):16798
PubMed ID: 33033327
DOI: 10.1038/s41598-020-73991-4
|
18498
Demirci S, Leonard A, Tisdale JF.
Genome editing strategies for fetal hemoglobin induction in beta-hemoglobinopathies
Hum Mol Genet
2020
29(R1):R100-R106
PubMed ID: 32406490
DOI: 10.1093/hmg/ddaa088
|
18501
Steinberg MH.
Fetal Hemoglobin in Sickle Hemoglobinopathies: High HbF Genotypes and Phenotypes
J Clin Med
2020
9(11):3782
PubMed ID: 33238542
DOI: 10.3390/jcm9113782
|
18507
Venkatesan V, Srinivasan S, Babu P, Thangavel S.
Manipulation of Developmental Gamma-Globin Gene Expression: an Approach for Healing Hemoglobinopathies
Mol Cell Biol
2020
41(1):e00253-20
PubMed ID: 33077498
DOI: 10.1128/MCB.00253-20
|
18536
Tasca F, Wang Q, Gonçalves MAFV.
Adenoviral Vectors Meet Gene Editing: A Rising Partnership for the Genomic Engineering of Human Stem Cells and Their Progeny
Cells
2020
9(4):953
PubMed ID: 32295080
DOI: 10.3390/cells9040953
|
6747
Daniels DE, Downes DJ, Ferrer-Vicens I, Ferguson DCJ, Singleton BK, Wilson MC, Trakarnsanga K, Kurita R, Nakamura Y, Anstee DJ, Frayne J
Comparing the two leading erythroid lines BEL-A and HUDEP-2.
Haematologica
2020
105(8):e389-e394
PubMed ID: 31753923
DOI: 10.3324/haematol.2019.229211
|
6796
Balogh P, Adelman ER, Pluvinage JV, Capaldo BJ, Freeman KC, Singh S, Elagib KE, Nakamura Y, Kurita R, Sashida G, Zunder ER, Li H, Gru AA, Price EA, Schrier SL, Weissman IL, Figueroa ME, Pang WW, Goldfarb AN.
RUNX3 levels in human hematopoietic progenitors are regulated by aging and dictate erythroid-myeloid balance.
Haematologica
2020
105(4):905-913
PubMed ID: 31171641
DOI: 10.3324/haematol.2018.208918
|
8959
Liren Wang, Linxi Li, Yanlin Ma, Handan Hu 1, Qi Li, Yang Yang, Wenbang Liu, Shuming Yin, Wei Li, Bin Fu, Ryo Kurita, Yukio Nakamura, Mingyao Liu, Yongrong Lai, Dali Li
Reactivation of γ-Globin Expression Through Cas9 or Base Editor to Treat β-Hemoglobinopathies
Cell Res
2020
30 (3), 276-278
PubMed ID: 31911671
DOI: 10.1038/s41422-019-0267-z
|
8964
Jun Zhan, Maria Johnson Irudayam, Yukio Nakamura, Ryo Kurita, Arthur W Nienhuis
High Level of Fetal-Globin Reactivation by Designed Transcriptional Activator-Like Effector
Blood Adv
2020
4 (4), 687-695
PubMed ID: 32084259
DOI: 10.1182/bloodadvances.2019000482
|
9631
Morgan RA, Ma F, Unti MJ, Brown D, Ayoub PG, Tam C, Lathrop L, Aleshe B, Kurita R, Nakamura Y, Senadheera S, Wong RL, Hollis RP, Pellegrini M, Kohn DB.
Creating New β-globin-Expressing Lentiviral Vectors by High-Resolution Mapping of Locus Control Region Enhancer Sequences
Mol Ther Methods Clin Dev
2020
17:999-1013
PubMed ID: 32426415
DOI: 10.1016/j.omtm.2020.04.006
|
18519
Demirci S, Leonard A, Haro-Mora JJ, Uchida N, Tisdale JF.
CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and Challenges
Adv Exp Med Biol
2019
1144:37-52
PubMed ID: 30715679
DOI: 10.1007/5584_2018_331
|
18542
Katsantoni E.
Omics Studies in Hemoglobinopathies
Mol Diagn Ther
2019
23(2):223-234
PubMed ID: 30712217
DOI: 10.1007/s40291-019-00386-1
|
6743
Chung JE, Magis W, Vu J, Heo SJ, Wartiovaara K, Walters MC, Kurita R, Nakamura Y, Boffelli D, Martin DIK, Corn JE, DeWitt MA
CRISPR-Cas9 interrogation of a putative fetal globin repressor in human erythroid cells.
PLoS One
2019
14(1):e0208237
PubMed ID: 30645582
DOI: 10.1371/journal.pone.0208237
|
6744
Couch T, Murphy Z, Getman M, Kurita R, Nakamura Y, Steiner LA.
Human erythroblasts with c-Kit activating mutations have reduced cell culture costs and remain capable of terminal maturation.
Exp Hematol
2019
19-24.e4
PubMed ID: 31004744
DOI: 10.1016/j.exphem.2019.04.001
|
6752
Svetlana Soboleva , Ryo Kurita, PhD , Fredrik Ek, PhD , Rita Alves , Roger Olsson, PhD , Yukio Nakamura, MD PhD , Kenichi Miharada, PhD
Identification of Potential Chemical Compounds Able to Trigger Enucleation of Immortalized Human Erythroid Cell Lines
Blood
2019
134 (Supplement_1): 951
DOI: 10.1182/blood-2019-128427
|
6759
Koya Ono, MD , Tohru Fujiwara, MD PhD , Kei Saito, MD PhD , Chie Suzuki , Noriyuki Takahashi , Koichi Onodera, MD PhD , Satoshi Ichikawa, MD PhD , Noriko Fukuhara, MD PhD , Yasushi Onishi, MD PhD , Hisayuki Yokoyama, MD PhD , Yukio Nakamura, MD PhD , Hideo Harigae, MD PhD
Molecular Characterization and Novel Therapeutic Strategy for X-Linked Sideroblastic Anemia Associated with ALAS2 Missense Variants
Blood
2019
134 (Supplement_1): 3530
DOI: 10.1182/blood-2019-124810
|
6763
Ingrid Grazielle Sousa, BSc, MSc , Priscila Keiko Matsumoto Martin, PhD , Dulcinéia Martins de Albuquerque, BSc, PhD , Carolina Lanaro, BSc, PhD , Ryo Kurita, PhD , Yukio Nakamura, MD PhD , Fernando Ferreira Costa, MD PhD
Knockdown of HNF4A Gene Increases Fetal Hemoglobin Synthesis in Hudep-2
Blood
2019
134 (Supplement_1): 968
DOI: 10.1182/blood-2019-130920
|
6768
Tohru Fujiwara, MD PhD , Chie Suzuki , Tetsuro Ochi , Koya Ono, MD , Kei Saito , Noriko Fukuhara, MD PhD , Yasushi Onishi, MD PhD , Hisayuki Yokoyama, MD PhD , Shinichi Fujimaki , Yukio Nakamura, MD PhD , Hideo Harigae, MD PhD
Characterization of Congenital Sideroblastic Anemia Model Due to ABCB7 Defects: How Do Defects in Iron-Sulfur Cluster Metabolism Lead to Ring Sideroblast Formation?
Blood
2019
134 (Supplement_1): 2232
DOI: 10.1182/blood-2019-123918
|
6770
Melanie Demers, PhD , Sarah Sturtevant, BSc , Kevin Guertin, PhD , Dipti Gupta , Kunal Desai, MS , Benjamin Vieira, BS , Alexandra Hicks, PhD , Ayman Ismail, PhD , Yukio Nakamura, MD PhD , Bronner Goncalves, MD PhD , Giuseppe Di Caprio, PhD , Ethan Schonbrun, PhD , Scott Hansen, BS , Martin K. Safo, PhD , David K. Wood, PhD , John M. Higgins, MD PhD , David R. Light, PhD
MetAP2 Inhibition Modifies Hemoglobin S (HbS) to Delay Polymerization and Improve Blood Flow in Sickle Cell Disease
Blood
2019
134 (Supplement_1): 2260
DOI: 10.1182/blood-2019-128727
|
6771
Dipti Gupta , Sarah Sturtevant, BSc , Benjamin Vieira, BS , Yukio Nakamura, MD PhD , Sriram Krishnamoorthy, PhD , Melanie Demers, PhD
Characterization of a Genetically Engineered HUDEP2 Cell Line Harboring a Sickle Cell Disease Mutation As a Potential Research Tool for Preclinical Sickle Cell Disease Drug Discovery
Blood
2019
134 (Supplement_1): 3559
DOI: 10.1182/blood-2019-127330
|
6776
Orkin SH, Bauer DE.
Emerging Genetic Therapy for Sickle Cell Disease
Annu Rev Med
2019
70:257-271
PubMed ID: 30355263
DOI: 10.1146/annurev-med-041817-125507
|
6789
Yu X, Azzo A, Bilinovich SM, Li X, Dozmorov M, Kurita R, Nakamura Y, Williams DC Jr, Ginder GD.
Disruption of the MBD2-NuRD complex but not MBD3-NuRD induces high level HbF expression in human adult erythroid cells.
Haematologica
2019
104(12):2361-2371
PubMed ID: 31004025
DOI: 10.3324/haematol.2018.210963
|
6793
Kurita R, Funato K, Abe T, Watanabe Y, Shiba M, Tadokoro K, Nakamura Y, Nagai T, Satake M
Establishment and characterization of immortalized erythroid progenitor cell lines derived from a common cell source.
Exp Hematol
2019
69:11-16
PubMed ID: 30326248
DOI: 10.1016/j.exphem.2018.10.005
|
6799
Sher F, Hossain M, Seruggia D, Schoonenberg VAC, Yao Q, Cifani P, Dassama LMK, Cole MA, Ren C, Vinjamur DS, Macias-Trevino C, Luk K, McGuckin C, Schupp PG, Canver MC, Kurita R, Nakamura Y, Fujiwara Y, Wolfe SA, Pinello L, Maeda T, Kentsis A, Orkin SH, Bauer DE
Rational targeting of a NuRD subcomplex guided by comprehensive in situ mutagenesis.
Nat Genet
2019
51(7):1149-1159
PubMed ID: 31253978
DOI: 10.1038/s41588-019-0453-4
|
6811
Damien J. Downes, Ron Schwessinger, Stephanie J. Hill, Lea Nussbaum, Caroline Scott, Matthew E. Gosden, Priscila P. Hirschfeld, Jelena M. Telenius, Chris Q. Eijsbouts, Simon J. McGowan, Antony J. Cutler, Jon Kerry, Jessica L. Davies, Calliope A. Dendrou, Jamie R.J. Inshaw, Martin S.C. Larke, A. Marieke Oudelaar, Yavor Bozhilov, Andrew J. King, Richard C. Brown, Maria C. Suciu, James O.J. Davies, Philip Hublitz, Chris Fisher, Ryo Kurita, Yukio Nakamura, Gerton Lunter, Stephen Taylor, Veronica J. Buckle, John A. Todd, Douglas R. Higgs, & Jim R. Hughes.
An integrated platform to systematically identify causal variants and genes for polygenic human traits
bioRxiv
2019
DOI: 10.1101/813618
|
6815
Damena D, Denis A, Golassa L, Chimusa ER.
Genome-wide association studies of severe P. falciparum malaria susceptibility: progress, pitfalls and prospects.
BMC Med Genomics
2019
12(1):120
PubMed ID: 31409341
DOI: 10.1186/s12920-019-0564-x
|
6821
Finotti A, Fabbri E, Lampronti I, Gasparello J, Borgatti M, Gambari R.
MicroRNAs and Long Non-coding RNAs in Genetic Diseases.
Mol Diagn Ther
2019
23(2):155-171
PubMed ID: 30610665
DOI: 10.1007/s40291-018-0380-6
|
8953
Gabriella E Martyn, Beeke Wienert, Ryo Kurita, Yukio Nakamura, Kate G R Quinlan, Merlin Crossley
A Natural Regulatory Mutation in the Proximal Promoter Elevates Fetal globin Expression by Creating a De Novo GATA1 Site
Blood
2019
133 (8), 852-856
PubMed ID: 30617196
DOI: 10.1182/blood-2018-07-863951
|
9888
Dipti Gupta, Samuel Lessard, PhD, Nancy Moore, Jicheng Duan, PhD, Yukio Nakamura, MD PhD, Feng-Chun Yang, MD PhD, Alexandra Hicks, PhD, David R. Light, PhD, Sriram Krishnamoorthy, PhD
Genetic Activation of NRF2 By KEAP1 Inhibition Induces Fetal Hemoglobin Expression and Triggers Anti-Oxidant Stress Response in Erythroid Cells
Blood
2019
134 (Supplement_1): 210
DOI: 10.1182/blood-2019-129479
|
18361
Mir Hossain, Falak Sher, Davide Seruggia, Vivien Schoonenberg, Mitchel A. Cole, Paolo Cifani, Laura Dassama, Claudio Macias-Trevino, Matthew C. Canver, Ryo Kurita, Yukio Nakamura, Luca Pinello, Takahiro Maeda, Alex Kentsis, Stuart H. Orkin, Daniel E. Bauer
Rational Targeting of a NuRD Sub-Complex for Fetal Hemoglobin Induction Following Comprehensive in Situ Mutagenesis
Blood
2018
132:2342-2342
DOI: 10.1182/blood-2018-99-117043
|
18362
Priscila Keiko Matsumoto Martin, Dulcinéia Martins de Albuquerque, Carolina Lanaro, Ryo Kurita, Yukio Nakamura, Fernando F. Costa
A Single -195 C < G HBG1 Promoter Mediated By CRISPR/Cas9 Genome Editing Induces Fetal Hemoglobin Synthesis in Hudep-2
Blood
2018
132:3481-3481
DOI: 10.1182/blood-2018-99-118534
|
18363
Bin Sun, Valerie Miller, Karin P Potoka, Yukio Nakamura, Mark T Gladwin, Grant C. Bullock
Soluble Guanylate Cyclase Modulators Effect Fetal Hemoglobin Levels through a Non-cGMP-Protein Kinase G Signaling Pathway
Blood
2018
132:1060-1060
DOI: 10.1182/blood-2018-99-120306
|
18515
Philipsen S, Hardison RC.
Evolution of hemoglobin loci and their regulatory elements
Blood Cells Mol Dis
2018
70:2-12
PubMed ID: 28811072
DOI: 10.1016/j.bcmd.2017.08.001
|
18537
Thein SL.
Molecular basis of β thalassemia and potential therapeutic targets
Blood Cells Mol Dis
2018
70:54-65
PubMed ID: 28651846
DOI: 10.1016/j.bcmd.2017.06.001
|
18549
Zhang J, Yan J, Zeng F.
Recent Progress on Genetic Diagnosis and Therapy for β-Thalassemia in China and Around the World
Hum Gene Ther
2018
29(2):197-203
PubMed ID: 29357712
DOI: 10.1089/hum.2017.228
|
4404
Moir-Meyer G, Cheong PL, Olijnik AA, Brown J, Knight S, King A, Kurita R, Nakamura Y, Gibbons RJ, Higgs DR, Buckle VJ, Babbs C.
Robust CRISPR/Cas9 Genome Editing of the HUDEP-2 Erythroid Precursor Line Using Plasmids and Single-Stranded Oligonucleotide Donors
Methods Protoc
2018
1(3)
PubMed ID: 31164570
DOI: 10.3390/mps1030028
|
4247
Liu J, Li Y, Tong J, Gao J, Guo Q, Zhang L, Wang B, Zhao H, Wang H, Jiang E, Kurita R, Nakamura Y, Tanabe O, Engel JD, Bresnick EH, Zhou J, Shi L.
Long non-coding RNA-dependent mechanism to regulate heme biosynthesis and erythrocyte development.
Nat Commun
2018
PubMed ID: 30349036
DOI: 10.1038/s41467-018-06883-x
|
4974
Morrison TA, Wilcox I, Luo HY, Farrell JJ, Kurita R, Nakamura Y, Murphy GJ, Cui S, Steinberg MH, Chui DHK.
A long noncoding RNA from the HBS1L-MYB intergenic region on chr6q23 regulates human fetal hemoglobin expression.
Blood Cells Mol Dis
2018
69:1-9
PubMed ID: 29227829
DOI: 10.1016/j.bcmd.2017.11.003
|
6728
Ghosh A, Garee G, Sweeny EA, Nakamura Y, Stuehr DJ.
Hsp90 chaperones hemoglobin maturation in erythroid and nonerythroid cells.
Proc Natl Acad Sci U S A
2018
115(6):E1117-E1126
PubMed ID: 29358373
DOI: 10.1073/pnas.1717993115
|
6761
Lee E, Sivalingam J, Lim ZR, Chia G, Shi LG, Roberts M, Loh YH, Reuveny S, Oh SK.
Review: In vitro generation of red blood cells for transfusion medicine: Progress, prospects and challenges.
Biotechnol Adv
2018
36(8):2118-2128
PubMed ID: 30273713
DOI: 10.1016/j.biotechadv.2018.09.006
|
6773
Martyn GE, Wienert B, Yang L, Shah M, Norton LJ, Burdach J, Kurita R, Nakamura Y, Pearson RCM, Funnell APW, Quinlan KGR, Crossley M
Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding.
Nat Genet
2018
50(4):498-503
PubMed ID: 29610478
DOI: 10.1038/s41588-018-0085-0
|
6784
Yu L, Jearawiriyapaisarn N, Lee MP, Hosoya T, Wu Q, Myers G, Lim KC, Kurita R, Nakamura Y, Vojtek AB, Rual JF, Engel JD.
BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.
Genes Dev
2018
32(23-24):1537-1549
PubMed ID: 30463901
DOI: 10.1101/gad.318436.118
|
6785
Sun S, Peng Y, Liu J.
Research advances in erythrocyte regeneration sources and methods in vitro.
Cell Regen (Lond)
2018
7(2):45-49
PubMed ID: 30671230
DOI: 10.1016/j.cr.2018.10.001
|
6786
Loucari CC, Patsali P, van Dijk TB, Stephanou C, Papasavva P, Zanti M, Kurita R, Nakamura Y, Christou S, Sitarou M, Philipsen S, Lederer CW, Kleanthous M.
Rapid and Sensitive Assessment of Globin Chains for Gene and Cell Therapy of Hemoglobinopathies.
Hum Gene Ther Methods
2018
29(1):60-74
PubMed ID: 29325430
DOI: 10.1089/hgtb.2017.190
|
6787
Vinjamur DS, Bauer DE, Orkin SH
Recent progress in understanding and manipulating haemoglobin switching for the haemoglobinopathies.
Br J Haematol
2018
180(5):630-643
PubMed ID: 29193029
DOI: 10.1111/bjh.15038
|
6788
Liu N, Hargreaves VV, Zhu Q, Kurland JV, Hong J, Kim W, Sher F, Macias-Trevino C, Rogers JM, Kurita R, Nakamura Y, Yuan GC, Bauer DE, Xu J, Bulyk ML, Orkin SH.
Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch.
Cell
2018
173(2):430-442.e17
PubMed ID: 29606353
DOI: 10.1016/j.cell.2018.03.016
|
6790
Khalil S, Delehanty L, Grado S, Holy M, White Z 3rd, Freeman K, Kurita R, Nakamura Y, Bullock G, Goldfarb A.
Iron modulation of erythropoiesis is associated with Scribble-mediated control of the erythropoietin receptor.
J Exp Med
2018
215(2):661-679
PubMed ID: 29282252
DOI: 10.1084/jem.20170396
|
6798
Lei Yu, Natee Jearawiriyapaisarn, Mary P. Lee, Tomonori Hosoya, Qingqing Wu, Greggory Myers, Kim-Chew Lim, Ryo Kurita, Yukio Nakamura, Anne B. Vojtek, View ORCID ProfileJean-François Rual, View ORCID ProfileJames Douglas Engel
BAP1 deubiquitinase is a potent repressor of fetal hemoglobin biosynthesis
bioRxiv
2018
DOI: 10.1101/346619
|
6807
Shukla A, Huangfu D.
Decoding the noncoding genome via large-scale CRISPR screens.
Curr Opin Genet Dev
2018
52:70-76
PubMed ID: 29913329
DOI: 10.1016/j.gde.2018.06.001
|
6813
Wienert B, Martyn GE, Funnell APW, Quinlan KGR, Crossley M.
Wake-up Sleepy Gene: Reactivating Fetal Globin for β-Hemoglobinopathies.
Trends Genet
2018
34(12):927-940
PubMed ID: 30287096
DOI: 10.1016/j.tig.2018.09.004
|
6817
Lau CH, Suh Y.
CRISPR-based strategies for studying regulatory elements and chromatin structure in mammalian gene control.
Mamm Genome
2018
29(3-4):205-228
PubMed ID: 29196861
DOI: 10.1007/s00335-017-9727-2
|
6819
Paikari A, Sheehan VA.
Fetal haemoglobin induction in sickle cell disease.
Br J Haematol
2018
180(2):189-200
PubMed ID: 29143315
DOI: 10.1111/bjh.15021
|
8954
Tyler A Couch, BS , Zachary C. Murphy, PhD , Michael Getman, MS , Ryo Kurita, PhD , Yukio Nakamura, MD PhD , Laurie A. Steiner, MD
Human Erythroblasts with c-Kit Activating Mutations Have Reduced Cell Culture Costs and Remain Capable of Terminal Maturation and Enucleation
Blood
2018
132 (Supplement 1): 2315
DOI: 10.1182/blood-2018-99-117157
|
8956
Laura Breda, PhD , Valentina Ghiaccio, PhD , Hanyia Zaidi , Silvia Pires Lourenco, MSc , Carla Casu , Kim Smith-Whitley, MD , Janet L. Kwiatkowski, MD , Vanessa Carrion, RN, CPN , Virginia Guzikowski, RN, MSN, CRNP , Ryo Kurita, PhD , Yukio Nakamura, MD PhD ,
Improved Lentiviral Vectors for the Cure of Hemoglobinopathies
Blood
2018
132 (Supplement 1): 3477
DOI: 10.1182/blood-2018-99-111319
|
8958
Yuxuan Wu, PhD , Mitchel A. Cole, BS , Abdou Mousas , Jing Zeng, MD , Qiuming Yao, PhD , Divya Vinjamur, PhD , Ryo Kurita, PhD , Yukio Nakamura, MD PhD , Luca Pinello, PhD , Guillame Lettre, PhD , Daniel E. Bauer, MD PhD
Comprehensive Integrated Genomic Perturbations Reveal Molecular Mechanisms of Red Blood Cell Trait Associations
Blood
2018
132 (Supplement 1): 532
DOI: 10.1182/blood-2018-99-120229
|
8965
Chiara Antoniani, Vasco Meneghini, Annalisa Lattanzi, Tristan Felix, Oriana Romano, Elisa Magrin, Leslie Weber, Giulia Pavani, Sara El Hoss, Ryo Kurita, Yukio Nakamura, Thomas J Cradick, Ante S Lundberg, Matthew Porteus, Mario Amendola, Wassim El Nemer, Marina Cavazzana, Fulvio Mavilio, Annarita Miccio
Induction of Fetal Hemoglobin Synthesis by CRISPR/Cas9-mediated Editing of the Human β-Globin Locus
Blood
2018
131 (17), 1960-1973
PubMed ID: 29519807
DOI: 10.1182/blood-2017-10-811505
|
8968
Tyler A Couch, BS , Zachary C. Murphy, PhD , Jacquelyn Lillis, MS , Michael Getman, MS , Paul D. Kingsley, PhD , Ryo Kurita, PhD , Yukio Nakamura, MD PhD , Laurie A. Steiner, MD
High-Level Setd8 Expression Is Important for Establishment of Normal Patterns of Erythroid Gene Expression and Is Essential for Stress Erythropoiesis
Blood
2018
132 (Supplement 1): 499
DOI: 10.1182/blood-2018-99-116609
|
18408
Falak Sher, Vivien Schoonenberg, Mitchel A. Cole, Claudio Macias-Trevino, Paolo Cifani, Patrick G Schupp, Matthew C. Canver, Ryo Kurita, Yukio Nakamur, Stuart Orkin, Alex Kentsi, Luca Pinello, Takahiro Maeda, Daniel E. Bauer
High-Resolution CRISPR Functional Genomics Reveals Critical Vulnerabilities of the NuRD Complex for Fetal Hemoglobin Control
Blood
2017
130:286
DOI: 10.1182/blood.V130.Suppl_1.286.286
|
18534
Lu Q, Livi GP, Modha S, Yusa K, Macarrón R, Dow DJ.
Applications of CRISPR genome editing technology in drug target identification and validation
Expert Opin Drug Discov
2017
12(6):541-552
PubMed ID: 28388235
DOI: 10.1080/17460441.2017.1317244
|
4973
Wienert B, Martyn GE, Kurita R, Nakamura Y, Quinlan KGR1, Crossley M.
KLF1 drives the expression of fetal hemoglobin in British HPFH.
Blood
2017
130(6):803-807
PubMed ID: 28659276
DOI: 10.1182/blood-2017-02-767400
|
6750
Trakarnsanga K, Griffiths RE, Wilson MC, Blair A, Satchwell TJ, Meinders M, Cogan N, Kupzig S, Kurita R, Nakamura Y, Toye AM, Anstee DJ, Frayne J.
An immortalized adult human erythroid line facilitates sustainable and scalable generation of functional red cells.
Nat Commun
2017
8:14750
PubMed ID: 28290447
DOI: 10.1038/ncomms14750
|
6765
Yankai Zhang, PhD , Ryo Kurita, PhD , Yukio Nakamura, MD PhD , Vivien Sheehan, MD PhD
Screening Fetal Hemoglobin Inducing Compounds in Human Umbilical Cord Blood-Derived Erythroid Progenitor Cells
Blood
2017
130 (Supplement 1): 2222
DOI: 10.1182/blood.V130.Suppl_1.2222.2222
|
6777
Lessard S, Gatof ES, Beaudoin M, Schupp PG, Sher F, Ali A, Prehar S, Kurita R, Nakamura Y, Baena E, Ledoux J, Oceandy D, Bauer DE, Lettre G.
An erythroid-specific ATP2B4 enhancer mediates red blood cell hydration and malaria susceptibility.
J Clin Invest
2017
127(8):3065-3074
PubMed ID: 28714864
DOI: 10.1172/JCI94378
|
6778
Canver MC, Lessard S, Pinello L, Wu Y, Ilboudo Y, Stern EN, Needleman AJ, Galactéros F, Brugnara C, Kutlar A, McKenzie C, Reid M, Chen DD, Das PP, A Cole M, Zeng J, Kurita R, Nakamura Y, Yuan GC, Lettre G, Bauer DE, Orkin SH.
Variant-aware saturating mutagenesis using multiple Cas9 nucleases identifies regulatory elements at trait-associated loci.
Nat Genet
2017
49(4):625-634
PubMed ID: 28218758
DOI: 10.1038/ng.3793
|
6791
Hodonsky CJ, Jain D, Schick UM, Morrison JV, Brown L, McHugh CP, Schurmann C, Chen DD, Liu YM, Auer PL, Laurie CA, Taylor KD, Browning BL, Li Y, Papanicolaou G1, Rotter JI, Kurita R, Nakamura Y, Browning SR, Loos RJF, North KE, Laurie CC, Thornton TA, Pankratz N, Bauer DE, Sofer T, Reiner AP.
Genome-wide association study of red blood cell traits in Hispanics/Latinos: The Hispanic Community Health Study/Study of Latinos.
PLoS Genet
2017
13(4):e1006760
PubMed ID: 28453575
DOI: 10.1371/journal.pgen.1006760
|
6803
Habara AH, Shaikho EM, Steinberg MH.
Fetal hemoglobin in sickle cell anemia: The Arab-Indian haplotype and new therapeutic agents.
Am J Hematol
2017
92(11):1233-1242
PubMed ID: 28736939
DOI: 10.1002/ajh.24872
|
6818
Ipe J, Swart M, Burgess KS, Skaar TC.
High-Throughput Assays to Assess the Functional Impact of Genetic Variants: A Road Towards Genomic-Driven Medicine.
Clin Transl Sci
2017
10(2):67-77
PubMed ID: 28213901
DOI: 10.1111/cts.12440
|
8824
Yan Dai, PhD , Tyngwei Chen , Heba Ijaz , Elizabeth Cho , Ryo Kurita, PhD , Yukio Nakamura, MD PhD , Martin H. Steinberg, MD
SIRT1 Increases the Expression of Fetal Hemoglobin Genes in Human Adult and Cord Blood Erythroblasts
Blood
2017
130 (Supplement 1): 287
DOI: 10.1182/blood.V130.Suppl_1.287.287
|
8955
Silvia Pires Lourenco, MSc , Amaliris Gonzalez, PhD , Tobias Raabe, PhD , Ryo Kurita, PhD , Yukio Nakamura, MD PhD , Laura Breda, PhD , Stefano Rivella, PhD
Generation of New Cell Models to Screen Improved Vectors for Functional Hemoglobin Expression
Blood
2017
130 (Supplement 1): 5563
DOI: 10.1182/blood.V130.Suppl_1.5563.5563
|
8962
Laura J Norton, Alister P W Funnell, Jon Burdach, Beeke Wienert, Ryo Kurita, Yukio Nakamura, Sjaak Philipsen, Richard C M Pearson, Kate G R Quinlan, Merlin Crossley
KLF1 Directly Activates Expression of the Novel Fetal Globin Repressor ZBTB7A/LRF in Erythroid Cells
Blood Adv
2017
1 (11), 685-692
PubMed ID: 29296711
DOI: 10.1182/bloodadvances.2016002303
|
8966
Shadi Khalil, Maja Holy, Stephen Grado, Robert Fleming, Ryo Kurita, Yukio Nakamura, Adam Goldfarb
A Specialized Pathway for Erythroid Iron Delivery Through Lysosomal Trafficking of Transferrin Receptor 2
Blood Adv
2017
1 (15), 1181-1194
PubMed ID: 29296759
DOI: 10.1182/bloodadvances.2016003772
|
8967
Brian M Dulmovits, MS , Julien Papoin, MS , Jian Hua Li, MS , Ryo Kurita, PhD , Yukio Nakamura, MD PhD , Yousef Al-Abed, MD , Luanne L. Peters, PhD , Betty Diamond, MD , Anupama Narla, MD , Jeffrey M Lipton, MDPhD , Mohandas Narla, DSc , Kevin Tracey, MD , Lionel Blanc, PhD
High Mobility Group Box 1 Protein (HMGB1) Mediates Anemia of Inflammation through Lineage Skewing and Direct Inhibition of EPO Signaling
Blood
2017
130 (Supplement 1): 2196
DOI: 10.1182/blood.V130.Suppl_1.2196.2196
|
18518
Hu X.
CRISPR/Cas9 system and its applications in human hematopoietic cells
Blood Cells Mol Dis
2016
62:6-12
PubMed ID: 27736664
DOI: 10.1016/j.bcmd.2016.09.003
|
18530
Sripichai O, Fucharoen S.
Fetal hemoglobin regulation in β-thalassemia: heterogeneity, modifiers and therapeutic approaches
Expert Rev Hematol
2016
9(12):1129-1137.
PubMed ID: 27801605
DOI: 10.1080/17474086.2016.1255142
|
6762
Masuda T, Wang X, Maeda M, Canver MC, Sher F, Funnell AP, Fisher C, Suciu M, Martyn GE, Norton LJ, Zhu C, Kurita R, Nakamura Y, Xu J, Higgs DR, Crossley M, Bauer DE, Orkin SH, Kharchenko PV, Maeda T.
Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin.
Science
2016
351(6270):285-9
PubMed ID: 26816381
DOI: 10.1126/science.aad3312
|
6764
Traxler EA, Yao Y, Wang YD, Woodard KJ, Kurita R, Nakamura Y, Hughes JR, Hardison RC, Blobel GA, Li C, Weiss MJ.
A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition.
Nat Med
2016
22(9):987-90
PubMed ID: 27525524
DOI: 10.1038/nm.4170
|
6774
Orkin SH.
Recent advances in globin research using genome-wide association studies and gene editing.
Ann N Y Acad Sci
2016
368(1):5-10
PubMed ID: 26866328
DOI: 10.1111/nyas.13001
|
6795
Smith EC, Orkin SH.
Hemoglobin genetics: recent contributions of GWAS and gene editing.
Hum Mol Genet
2016
25(R2):R99-R105
PubMed ID: 27340226
DOI: 10.1093/hmg/ddw170
|
6802
Wright JB, Sanjana NE.
CRISPR Screens to Discover Functional Noncoding Elements.
Trends Genet
2016
32(9):526-529
PubMed ID: 27423542
DOI: 10.1016/j.tig.2016.06.004
|
6820
Cottle RN, Lee CM, Bao G.
Treating hemoglobinopathies using gene-correction approaches: promises and challenges.
Hum Genet
2016
135(9):993-1010
PubMed ID: 27314256
DOI: 10.1007/s00439-016-1696-0
|
8963
Sriram Krishnamoorthy , Dipti Gupta , William E. Hobbs, MD PhD , Christine Loh, PhD , David R. Light , Robert Peters, PhD , Sarah Sturtevant , Betty Pace, MD , Yukio Nakamura , Brian Lucas , Benjamin F. Vieira
Nrf2 activation and fetal hemoglobin induction in sickle cell disease
Blood
2016
128 (22): 4840
DOI: 10.1182/blood.V128.22.4840.4840
|
18367
Takeshi Masuda, Xin Wang, Manami Maeda, Matthew C. Canver, Falak Sher, Alister P.W. Funnell, Chris Fisher, Maria Suciu, Gabriella E. Martyn, Laura J. Norton, Ruijia Zhu, Ryo Kurita, Yukio Nakamura, Jian Xu, Douglas R. Higgs, Merlin Crossley, Daniel E. Bauer, Stuart H. Orkin, Peter V. Kharchenko, Takahiro Maeda
The LRF/ZBTB7A Transcription Factor Is a BCL11A-Independent Repressor of Fetal Hemoglobin
Blood
2015
126:2-2
DOI: 10.1182/blood.V126.23.2.2
|
6756
Kim YH, Kim HO, Baek EJ, Kurita R, Cha HJ, Nakamura Y, Kim H.
Rh D blood group conversion using transcription activator-like effector nucleases.
Nat Commun
2015
6:7451
PubMed ID: 26078220
DOI: 10.1038/ncomms8451
|
6775
Canver MC, Smith EC, Sher F, Pinello L, Sanjana NE, Shalem O, Chen DD, Schupp PG, Vinjamur DS, Garcia SP, Luc S, Kurita R, Nakamura Y, Fujiwara Y, Maeda T, Yuan GC, Zhang F, Orkin SH, Bauer DE.
BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis.
Nature
2015
527(7577):192-7
PubMed ID: 26375006
DOI: 10.1038/nature15521
|
6742
Kurita R, Suda N, Sudo K, Miharada K, Hiroyama T, Miyoshi H, Tani K, Nakamura Y.
Establishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells.
PLoS One
2013
8(3):e59890
PubMed ID: 23533656
DOI: 10.1371/journal.pone.0059890
|
User's Publication |
22109
Lv A, Chen M, Zhang S, Zhao W, Li J, Lin S, Zheng Y, Lin N, Xu L, Huang H.
Upregulation of miR‑6747‑3p affects red blood cell lineage development and induces fetal hemoglobin expression by targeting BCL11A in β‑thalassemia.
Mol Med Rep
2025
31(1)
PubMed ID: 39450557
DOI: 10.3892/mmr.2024.13372
|
17723
Mehta S, Buyanbat A, Orkin S, Nabet B.
High-efficiency knock-in of degradable tags (dTAG) at endogenous loci in cell lines
Methods Enzymol
2023
681:1-22
PubMed ID: 36764753
DOI: 10.1016/bs.mie.2022.08.045
|
18374
Wu J, Moriwaki K, Asuka T, Nakai R, Kanda S, Taniguchi M, Sugiyama T, Yoshimura SI, Kunii M, Nagasawa T, Hosen N, Miyoshi E, Harada A.
EHBP1L1, an apicobasal polarity regulator, is critical for nuclear polarization during enucleation of erythroblasts
Blood Adv
2023
7(14):3382-3394
PubMed ID: 37042948
DOI: 10.1182/bloodadvances.2022008930
|
18393
Zhang Y, Xie H, Liang G, Qin Y, Wei X, Ning S, Liang Y, Liang X, Xie Y, Lin Z, Zhu D, Lin J, Xiong F, Xu X, Shang X.
A novel gain-of-function PIP4K2A mutation elevates the expression of β-globin and aggravates the severity of α-thalassemia
Br J Haematol
2023
202(5):1018-1023
PubMed ID: 37423903
DOI: 10.1111/bjh.18967
|
18399
Boontanrart MY, Mächler E, Ponta S, Nelis JC, Preiano VG, Corn JE.
Engineering of the endogenous HBD promoter increases HbA2
Elife
2023
12:e85258
PubMed ID: 37265399
DOI: 10.7554/eLife.85258
|
18402
Shang S, Li X, Azzo A, Truong T, Dozmorov M, Lyons C, Manna AK, Williams DC Jr, Ginder GD.
MBD2a-NuRD binds to the methylated γ-globin gene promoter and uniquely forms a complex required for silencing of HbF expression
Proc Natl Acad Sci U S A
2023
120(25):e2302254120
PubMed ID: 37307480
DOI: 10.1073/pnas.2302254120
|
18434
Yang F, Xu S, Huang C, Shao Z, Hu Y, Yang Yang, Lai Y, Ke Q, Liang D, Wu Y.
Therapeutic genome editing of an aberrant splice site in β-thalassemia by CRISPR/Cas9 with multiple sgRNAs
Genes Dis
2023
11(1):15-18
PubMed ID: 37588192
DOI: 10.1016/j.gendis.2023.01.010
|
18436
Leighton GO, Shang S, Hageman S, Ginder GD, Williams DC Jr.
Analysis of the complex between MBD2 and the histone deacetylase core of NuRD reveals key interactions critical for gene silencing
Proc Natl Acad Sci U S A
2023
120(33):e2307287120
PubMed ID: 37552759
DOI: 10.1073/pnas.2307287120
|
18437
Wang X, McKillop WM, Dlugi TA, Faber ML, Alvarez-Argote J, Chambers CB, Wilber A, Medin JA.
A mass spectrometry assay for detection of endogenous and lentiviral engineered hemoglobin in cultured cells and sickle cell disease mice
J Gene Med
2023
e3567
PubMed ID: 37455676
DOI: 10.1002/jgm.3567
|
18438
Xue N, Liu X, Zhang D, Wu Y, Zhong Y, Wang J, Fan W, Jiang H, Zhu B, Ge X, Gonzalez RVL, Chen L, Zhang S, She P, Zhong Z, Sun J, Chen X, Wang L, Gu Z, Zhu P, Liu M, Li D, Zhong TP, Zhang X.
Improving adenine and dual base editors through introduction of TadA-8e and Rad51DBD
Nat Commun
2023
14(1):1224
PubMed ID: 36869044
DOI: 10.1038/s41467-023-36887-1
|
18444
Baro B, Kim CY, Lin C, Kongsomboonvech AK, Tetard M, Peterson NA, Salinas ND, Tolia NH, Egan ES.
Plasmodium falciparum exploits CD44 as a co-receptor for erythrocyte invasion
Blood
2023
2023020831
PubMed ID: 37832027
DOI: 10.1182/blood.2023020831
|
18447
Cervellera CF, Mazziotta C, Di Mauro G, Iaquinta MR, Mazzoni E, Torreggiani E, Tognon M, Martini F, Rotondo JC.
Immortalized erythroid cells as a novel frontier for in vitro blood production: current approaches and potential clinical application
Stem Cell Res Ther
2023
14(1):139
PubMed ID: 37226267
DOI: 10.1186/s13287-023-03367-8
|
18489
Kaur G, Ren R, Hammel M, Horton JR, Yang J, Cao Y, He C, Lan F, Lan X, Blobel GA, Blumenthal RM, Zhang X, Cheng X.
Allosteric autoregulation of DNA binding via a DNA-mimicking protein domain: a biophysical study of ZNF410-DNA interaction using small angle X-ray scattering
Nucleic Acids Res
2023
51(4):1674-1686
PubMed ID: 36660822
DOI: 10.1093/nar/gkac1274
|
18499
Ren R, Horton JR, Chen Q, Yang J, Liu B, Huang Y, Blumenthal RM, Zhang X, Cheng X.
Structural basis for transcription factor ZBTB7A recognition of DNA and effects of ZBTB7A somatic mutations that occur in human acute myeloid leukemia
J Biol Chem
2023
299(2):102885
PubMed ID: 36626981
DOI: 10.1016/j.jbc.2023.102885
|
18502
Nai A, Cordero-Sanchez C, Tanzi E, Pagani A, Silvestri L, Di Modica SM.
Cellular and animal models for the investigation of β-thalassemia
Blood Cells Mol Dis
2023
102761
PubMed ID: 37271682
DOI: 10.1016/j.bcmd.2023.102761
|
18506
Zhou Y, Dogiparthi VR, Ray S, Schaefer MA, Harris HL, Rowley MJ, Hewitt KJ.
Defining a cohort of anemia-activated cis elements reveals a mechanism promoting erythroid precursor function
Blood Adv
2023
7(20):6325-6338
PubMed ID: 36809789
DOI: 10.1182/bloodadvances.2022009163
|
18511
Brusson M, Chalumeau A, Martinucci P, Romano O, Felix T, Poletti V, Scaramuzza S, Ramadier S, Masson C, Ferrari G, Mavilio F, Cavazzana M, Amendola M, Miccio A.
Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies
Mol Ther Nucleic Acids
2023
32:229-246
PubMed ID: 37090420
DOI: 10.1016/j.omtn.2023.03.012
|
21007
Yin M, Izadi M, Tenglin K, Viennet T, Zhai L, Zheng G, Arthanari H, Dassama LMK, Orkin SH.
Evolution of nanobodies specific for BCL11A.
Proc Natl Acad Sci U S A
2023
120(3)
PubMed ID: 36626555
DOI: 10.1073/pnas.2218959120
|
21187
Badat M, Ejaz A, Hua P, Rice S, Zhang W, Hentges LD, Fisher CA, Denny N, Schwessinger R, Yasara N, Roy NBA, Issa F, Roy A, Telfer P, Hughes J, Mettananda S, Higgs DR, Davies JOJ.
Direct correction of haemoglobin E β-thalassaemia using base editors.
Nat Commun
2023
14(1):2238
PubMed ID: 37076455
DOI: 10.1038/s41467-023-37604-8
|
21274
Chaand M, Fiore C, Johnston B, D'Ippolito A, Moon DH, Carulli JP, Shearstone JR.
Erythroid lineage chromatin accessibility maps facilitate identification and validation of NFIX as a fetal hemoglobin repressor.
Commun Biol
2023
6(1):640
PubMed ID: 37316562
DOI: 10.1038/s42003-023-05025-4
|
21304
Mayuranathan T, Newby GA, Feng R, Yao Y, Mayberry KD, Lazzarotto CR, Li Y, Levine RM, Nimmagadda N, Dempsey E, Kang G, Porter SN, Doerfler PA, Zhang J, Jang Y, Chen J, Bell HW, Crossley M, Bhoopalan SV, Sharma A, Tisdale JF, Pruett-Miller SM, Cheng Y, Tsai SQ, Liu DR, Weiss MJ, Yen JS.
Potent and uniform fetal hemoglobin induction via base editing.
Nat Genet
2023
PubMed ID: 37400614
DOI: 10.1038/s41588-023-01434-7
|
21452
Simbula M, Manchinu MF, Mingoia M, Pala M, Asunis I, Caria CA, Perseu L, Shah M, Crossley M, Moi P, Ristaldi MS.
miR-365-3p mediates BCL11A and SOX6 erythroid-specific coregulation: A new player in HbF activation.
Mol Ther Nucleic Acids
2023
34:102025
PubMed ID: 37744176
DOI: 10.1016/j.omtn.2023.09.002
|
21464
Ravi NS, George A, Mohankumar KM.
Protocol for arrayed gRNA screening by base editors in mammalian cell lines using lentiviral system.
STAR Protoc
2023
4(4):102668
PubMed ID: 37922314
DOI: 10.1016/j.xpro.2023.102668
|
21484
Han W, Qiu HY, Sun S, Fu ZC, Wang GQ, Qian X, Wang L, Zhai X, Wei J, Wang Y, Guo YL, Cao GH, Ji RJ, Zhang YZ, Ma H, Wang H, Zhao M, Wu J, Bi L, Chen QB, Li Z, Yu L, Mou X, Yin H, Yang L, Chen J, Yang B, Zhang Y.
Base editing of the HBG promoter induces potent fetal hemoglobin expression with no detectable off-target mutations in human HSCs.
Cell Stem Cell
2023
PubMed ID: 37989316
DOI: 10.1016/j.stem.2023.10.007
|
17576
Forester CM, Oses-Prieto JA, Phillips NJ, Miglani S, Pang X, Byeon GW, DeMarco R, Burlingame A, Barna M, Ruggero D.
Regulation of eIF4E guides a unique translational program to control erythroid maturation
Sci Adv
2022
8(51):eadd3942
PubMed ID: 36563140
DOI: 10.1126/sciadv.add3942
|
17720
Wang D, Tanaka-Yano M, Meader E, Kinney MA, Morris V, Lummertz da Rocha E, Liu N, Liu T, Zhu Q, Orkin SH, North TE, Daley GQ, Rowe RG.
Developmental maturation of the hematopoietic system controlled by a Lin28b-let-7-Cbx2 axis
Cell Rep
2022
39(1):110587
PubMed ID: 35385744
DOI: 10.1016/j.celrep.2022.110587
|
18195
Park SH, Cao M, Pan Y, Davis TH, Saxena L, Deshmukh H, Fu Y, Treangen T, Sheehan VA, Bao G.
Comprehensive analysis and accurate quantification of unintended large gene modifications induced by CRISPR-Cas9 gene editing
Sci Adv
2022
8(42):eabo7676
PubMed ID: 36269834
DOI: 10.1126/sciadv.abo7676
|
18371
Topfer SK, Feng R, Huang P, Ly LC, Martyn GE, Blobel GA, Weiss MJ, Quinlan KGR, Crossley M.
Disrupting the adult globin promoter alleviates promoter competition and reactivates fetal globin gene expression
Blood
2022
139(14):2107-2118
PubMed ID: 35090172
DOI: 10.1182/blood.2021014205
|
18373
Shrestha D, Bag A, Wu R, Zhang Y, Tang X, Qi Q, Xing J, Cheng Y.
Genomics and epigenetics guided identification of tissue-specific genomic safe harbors
Genome Biol
2022
23(1):199
PubMed ID: 36131352
DOI: 10.1186/s13059-022-02770-3
|
18382
Zhang H, Zhou Q, Chen H, Lu D.
Prime Editor 3 Mediated Beta-Thalassemia Mutations of the HBB Gene in Human Erythroid Progenitor Cells
Int J Mol Sci
2022
23(9):5002
PubMed ID: 35563395
DOI: 10.3390/ijms23095002
|
18390
Ginette Balbin-Cuesta, Katherine Rybkin, Greggory Myers, Rami Khoriaty
Identifying Novel Regulators of Erythroid Maturation and Proliferation Using a Genome-Scale CRISPR Activation Screen
Blood
2022
140:8170-8171
DOI: 10.1182/blood-2022-170108
|
18391
Yannis Hara, Emily Kawabata, Viktor T. Lemgart, Paola G. Bronson, Alexandra Hicks, Sriram Krishnamoorthy, Nicholas Watkins, Robert Peters, David J. Roberts, Emanuele Di Angelantonio, John Danesh, William Astle, Dirk S. Paul, Samuel Lessard, Adam S. Butterworth
Inhibition of MRP1 Induces Fetal Hemoglobin through NRF2 Activation to Protect Human Erythroid Cells from Sickling
Blood
2022
140:952-953
DOI: 10.1182/blood-2022-168169
|
18396
Greggory Myers, Lei Yu, Ginette Balbin-Cuesta, Ayse Bilge Ozel, James Douglas Engel, Rami Khoriaty
Identification of Novel Regulators of Erythropoiesis Using Whole-Genome CRISPR-Cas9 Screening
Blood
2022
140:8155-8156
DOI: 10.1182/blood-2022-170101
|
18409
Charlene Lam, Kevin Gillinder, Natalia Carvajal, Helen Lorraine Mitchell, Graham William Magor, Andrew Charles Perkins
Novel Immediate Direct Targets of EPO Signalling in Human Erythropoiesis
Blood
2022
140:1238-1238
DOI: 10.1182/blood-2022-168671
|
18410
David C. Williams, Gage Oliver Leighton, Parnika Agrawal, Glory Dan-Dukor, Shengzhe Shang, Gordon Ginder
ETO2 Recruitment of NuRD to the γ-Globin Locus Involves Multivalent Interaction with GATAD2A
Blood
2022
140:1939-1940
DOI: 10.1182/blood-2022-169694
|
18428
Shen F, Zheng G, Setegne M, Tenglin K, Izadi M, Xie H, Zhai L, Orkin SH, Dassama LMK.
A Cell-Permeant Nanobody-Based Degrader That Induces Fetal Hemoglobin
ACS Cent Sci
2022
8(12):1695-1703
PubMed ID: 36589886
DOI: 10.1021/acscentsci.2c00998
|
18435
Sun Y, Habara A, Le CQ, Nguyen N, Chen R, Murphy GJ, Chui DHK, Steinberg MH, Cui S.
Pharmacologic induction of PGC-1α stimulates fetal haemoglobin gene expression
Br J Haematol
2022
197(1):97-109
PubMed ID: 35118652
DOI: 10.1111/bjh.18042
|
18443
Mehta S, Buyanbat A, Kai Y, Karayel O, Goldman SR, Seruggia D, Zhang K, Fujiwara Y, Donovan KA, Zhu Q, Yang H, Nabet B, Gray NS, Mann M, Fischer ES, Adelman K, Orkin SH.
Temporal resolution of gene derepression and proteome changes upon PROTAC-mediated degradation of BCL11A protein in erythroid cells
Cell Chem Biol
2022
29(8):1273-1287
PubMed ID: 35839780
DOI: 10.1016/j.chembiol.2022.06.007
|
18492
Ramadier S, Chalumeau A, Felix T, Othman N, Aknoun S, Casini A, Maule G, Masson C, De Cian A, Frati G, Brusson M, Concordet JP, Cavazzana M, Cereseto A, El Nemer W, Amendola M, Wattellier B, Meneghini V, Miccio A.
Combination of lentiviral and genome editing technologies for the treatment of sickle cell disease
Mol Ther
2022
30(1):145-163
PubMed ID: 34418541
DOI: 10.1016/j.ymthe.2021.08.019
|
18500
Yichao Zhou, Linda Chee, Suhita Ray, Meg Schaefer, Venkatasai Rahul Dogiparthi, Jordan Rowley, Kyle J Hewitt
Anemia-Activated Cis Regulatory Requirements for Erythroid Regeneration
Blood
2022
140:701-701
DOI: 10.1182/blood-2022-167544
|
18509
Steinberg MH.
Targeting fetal hemoglobin expression to treat β hemoglobinopathies
Expert Opin Ther Targets
2022
26(4):347-359
PubMed ID: 35418266
DOI: 10.1080/14728222.2022.2066519
|
18564
Bircher C, Bieri J, Assaraf R, Leisi R, Ros C.
A Conserved Receptor-Binding Domain in the VP1u of Primate Erythroparvoviruses Determines the Marked Tropism for Erythroid Cells
Viruses
2022
14(2):420
PubMed ID: 35216013
DOI: 10.3390/v14020420
|
20716
Qin K, Huang P, Feng R, Keller CA, Peslak SA, Khandros E, Saari MS, Lan X, Mayuranathan T, Doerfler PA, Abdulmalik O, Giardine B, Chou ST, Shi J, Hardison RC, Weiss MJ, Blobel GA.
Dual function NFI factors control fetal hemoglobin silencing in adult erythroid cells.
Nat Genet
2022
PubMed ID: 35618846
DOI: 10.1038/s41588-022-01076-1
|
20782
Patino CA, Pathak N, Mukherjee P, Park SH, Bao G, Espinosa HD.
Multiplexed high-throughput localized electroporation workflow with deep learning-based analysis for cell engineering.
Sci Adv
2022
8(29):eabn7637
PubMed ID: 35867793
DOI: 10.1126/sciadv.abn7637
|
20889
Feng R, Mayuranathan T, Huang P, Doerfler PA, Li Y, Yao Y, Zhang J, Palmer LE, Mayberry K, Christakopoulos GE, Xu P, Li C, Cheng Y, Blobel GA, Simon MC, Weiss MJ.
Activation of γ-globin expression by hypoxia-inducible factor 1α.
Nature
2022
PubMed ID: 36224385
DOI: 10.1038/s41586-022-05312-w
|
20924
Antoniou P, Hardouin G, Martinucci P, Frati G, Felix T, Chalumeau A, Fontana L, Martin J, Masson C, Brusson M, Maule G, Rosello M, Giovannangeli C, Abramowski V, de Villartay JP, Concordet JP, Del Bene F, El Nemer W, Amendola M, Cavazzana M, Cereseto A, Romano O, Miccio A.
Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression.
Nat Commun
2022
13(1):6618
PubMed ID: 36333351
DOI: 10.1038/s41467-022-34493-1
|
18369
Hu Y, Stilp AM, McHugh CP, Rao S, Jain D, Zheng X, Lane J, Méric de Bellefon S, Raffield LM, Chen MH, Yanek LR, Wheeler M, Yao Y, Ren C, Broome J, Moon JY, de Vries PS, Hobbs BD, Sun Q, Surendran P, Brody JA, Blackwell TW, Choquet H, Ryan K, Duggirala R, Heard-Costa N, Wang Z, Chami N, Preuss MH, Min N, Ekunwe L, Lange LA, Cushman M, Faraday N, Curran JE, Almasy L, Kundu K, Smith AV, Gabriel S, Rotter JI, Fornage M, Lloyd-Jones DM, Vasan RS, Smith NL, North KE, Boerwinkle E, Becker LC, Lewis JP, Abecasis GR, Hou L, O'Connell JR, Morrison AC, Beaty TH, Kaplan R, Correa A, Blangero J, Jorgenson E, Psaty BM, Kooperberg C, Walton RT, Kleinstiver BP, Tang H, Loos RJF, Soranzo N, Butterworth AS, Nickerson D, Rich SS, Mitchell BD, Johnson AD, Auer PL, Li Y, Mathias RA, Lettre G, Pankratz N, Laurie CC, Laurie CA, Bauer DE, Conomos MP, Reiner AP, NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium.
Whole-genome sequencing association analysis of quantitative red blood cell phenotypes: The NHLBI TOPMed program
Am J Hum Genet
2021
108(5):874-893
PubMed ID: 33887194
DOI: 10.1016/j.ajhg.2021.04.003
|
18370
Uchida N, Ferrara F, Drysdale CM, Yapundich M, Gamer J, Nassehi T, DiNicola J, Shibata Y, Wielgosz M, Kim YS, Bauler M, Throm RE, Haro-Mora JJ, Demirci S, Bonifacino AC, Krouse AE, Linde NS, Donahue RE, Ryu B, Tisdale JF.
Sustained fetal hemoglobin induction in vivo is achieved by BCL11A interference and coexpressed truncated erythropoietin receptor
Sci Transl Med
2021
13(591):eabb0411
PubMed ID: 33910976
DOI: 10.1126/scitranslmed.abb0411
|
18383
Cheng Y, Shang X, Chen D, Pang D, Zhao C, Xu X.
MicroRNA-2355-5p regulates γ-globin expression in human erythroid cells by inhibiting KLF6
Br J Haematol
2021
193(2):401-405
PubMed ID: 33368182
DOI: 10.1111/bjh.17134
|
18384
Ruopeng Feng, Thiyagaraj Mayuranathan, Peng Huang, Phillip A Doerfler, Yichao Li, Yu Yao, Jingjing Zhang, Lance E. Palmer, Peng Xu, Kalin Mayberry, Shaela Wright, Chunliang Li, Yong Cheng, Gerd A. Blobel, M. Celeste Simon, Mitchell J. Weiss
Regulation of Fetal Hemoglobin Expression By the VHL-HIF1α Oxygen Sensing System
Blood
2021
138:574-574
DOI: 10.1182/blood-2021-149901
|
18388
Lin J, Ye Y, Shang X, Zhang Y, Wei X, Xu X.
TEA domain transcription factor 4 modulates repression of fetal haemoglobin by direct binding to the γ-globin gene promoters
Br J Haematol
2021
195(5):764-769
PubMed ID: 34569056
DOI: 10.1111/bjh.17786
|
18389
Gong Y, Zhang X, Zhang Q, Zhang Y, Ye Y, Yu W, Shao C, Yan T, Huang J, Zhong J, Wang L, Li Y, Wang L, Xu X.
A natural DNMT1 mutation elevates the fetal hemoglobin level via epigenetic derepression of the γ-globin gene in β-thalassemia
Blood
2021
137(12):1652-1657
PubMed ID: 33227819
DOI: 10.1182/blood.2020006425
|
18400
Li C, Georgakopoulou A, Mishra A, Gil S, Hawkins RD, Yannaki E, Lieber A.
In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal γ-globin in β-YAC mice
Blood Adv
2021
5(4):1122-1135
PubMed ID: 33620431
DOI: 10.1182/bloodadvances.2020003702
|
18406
Pavani G, Fabiano A, Laurent M, Amor F, Cantelli E, Chalumeau A, Maule G, Tachtsidi A, Concordet JP, Cereseto A, Mavilio F, Ferrari G, Miccio A, Amendola M.
Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells
Blood Adv
2021
5(5):1137-1153
PubMed ID: 33635334
DOI: 10.1182/bloodadvances.2020001996
|
18431
Boddu PC, Gupta AK, Kim JS, Neugebauer KM, Waldman T, Pillai MM.
Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase
Commun Biol
2021
4(1):1184
PubMed ID: 34645977
DOI: 10.1038/s42003-021-02690-1
|
18439
Lan X, Ren R, Feng R, Ly LC, Lan Y, Zhang Z, Aboreden N, Qin K, Horton JR, Grevet JD, Mayuranathan T, Abdulmalik O, Keller CA, Giardine B, Hardison RC, Crossley M, Weiss MJ, Cheng X, Shi J, Blobel GA.
ZNF410 Uniquely Activates the NuRD Component CHD4 to Silence Fetal Hemoglobin Expression
Mol Cell
2021
81(2):239-254.e8
PubMed ID: 33301730
DOI: 10.1016/j.molcel.2020.11.006
|
18440
Nualkaew T, Sii-Felice K, Giorgi M, McColl B, Gouzil J, Glaser A, Voon HPJ, Tee HY, Grigoriadis G, Svasti S, Fucharoen S, Hongeng S, Leboulch P, Payen E, Vadolas J.
Coordinated β-globin expression and α2-globin reduction in a multiplex lentiviral gene therapy vector for β-thalassemia
Mol Ther
2021
29(9):2841-2853
PubMed ID: 33940155
DOI: 10.1016/j.ymthe.2021.04.037
|
18442
Shen Y, Verboon JM, Zhang Y, Liu N, Kim YJ, Marglous S, Nandakumar SK, Voit RA, Fiorini C, Ejaz A, Basak A, Orkin SH, Xu J, Sankaran VG.
A unified model of human hemoglobin switching through single-cell genome editing
Nat Commun
2021
12(1):4991
PubMed ID: 34404810
DOI: 10.1038/s41467-021-25298-9
|
18446
Li C, Wang H, Georgakopoulou A, Gil S, Yannaki E, Lieber A.
In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model
Mol Ther
2021
29(2):822-837
PubMed ID: 32949495
DOI: 10.1016/j.ymthe.2020.09.001
|
18491
King AJ, Songdej D, Downes DJ, Beagrie RA, Liu S, Buckley M, Hua P, Suciu MC, Marieke Oudelaar A, Hanssen LLP, Jeziorska D, Roberts N, Carpenter SJ, Francis H, Telenius J, Olijnik AA, Sharpe JA, Sloane-Stanley J, Eglinton J, Kassouf MT, Orkin SH, Pennacchio LA, Davies JOJ, Hughes JR, Higgs DR, Babbs C.
Reactivation of a developmentally silenced embryonic globin gene
Nat Commun
2021
12(1):4439
PubMed ID: 34290235
DOI: 10.1038/s41467-021-24402-3
|
18504
Psatha N, Georgakopoulou A, Li C, Nandakumar V, Georgolopoulos G, Acosta R, Paschoudi K, Nelson J, Chee D, Athanasiadou A, Kouvatsi A, Funnell APW, Lieber A, Yannaki E, Papayannopoulou T.
Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo
Blood
2021
138(17):1540-1553
PubMed ID: 34086867
DOI: 10.1182/blood.2020010020
|
20126
Qi Q, Cheng L, Tang X, He Y, Li Y, Yee T, Shrestha D, Feng R, Xu P, Zhou X, Pruett-Miller S, Hardison RC, Weiss MJ, Cheng Y.
Dynamic CTCF binding directly mediates interactions among cis-regulatory elements essential for hematopoiesis.
Blood
2021
137(10):1327-1339
PubMed ID: 33512425
DOI: 10.1182/blood.2020005780
|
20255
Doerfler PA, Feng R, Li Y, Palmer LE, Porter SN, Bell HW, Crossley M, Pruett-Miller SM, Cheng Y, Weiss MJ.
Activation of γ-globin gene expression by GATA1 and NF-Y in hereditary persistence of fetal hemoglobin.
Nat Genet
2021
53(8):1177-1186
PubMed ID: 34341563
DOI: 10.1038/s41588-021-00904-0
|
20388
Downes DJ, Cross AR, Hua P, Roberts N, Schwessinger R, Cutler AJ, Munis AM, Brown J, Mielczarek O, de Andrea CE, Melero I, COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium, Gill DR, Hyde SC, Knight JC, Todd JA, Sansom SN, Issa F, Davies JOJ, Hughes JR.
Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus.
Nat Genet
2021
53(11):1606-1615
PubMed ID: 34737427
DOI: 10.1038/s41588-021-00955-3
|
20449
Georgolopoulos G, Psatha N, Iwata M, Nishida A, Som T, Yiangou M, Stamatoyannopoulos JA, Vierstra J.
Discrete regulatory modules instruct hematopoietic lineage commitment and differentiation.
Nat Commun
2021
12(1):6790
PubMed ID: 34815405
DOI: 10.1038/s41467-021-27159-x
|
16052
Xu P, Scott DC, Xu B, Yao Y, Feng R, Cheng L, Mayberry K, Wang YD, Bi W, Palmer LE, King MT, Wang H, Li Y, Fan Y, Alpi AF, Li C, Peng J, Papizan J, Pruett-Miller SM, Spallek R, Bassermann F, Cheng Y, Schulman BA, Weiss MJ.
FBXO11-mediated proteolysis of BAHD1 relieves PRC2-dependent transcriptional repression in erythropoiesis
Blood
2021
137(2):155-167.
PubMed ID: 33156908
DOI: 10.1182/blood.2020007809
|
16055
Liu N, Xu S, Yao Q, Zhu Q, Kai Y, Hsu JY, Sakon P, Pinello L, Yuan GC, Bauer DE, Orkin SH.
Transcription factor competition at the γ-globin promoters controls hemoglobin switching
Nat Genet
2021
53(4):511-520
PubMed ID: 33649594
DOI: 10.1038/s41588-021-00798-y
|
16059
Cheng L, Li Y, Qi Q, Xu P, Feng R, Palmer L, Chen J, Wu R, Yee T, Zhang J, Yao Y, Sharma A, Hardison RC, Weiss MJ, Cheng Y.
Single-nucleotide-level mapping of DNA regulatory elements that control fetal hemoglobin expression
Nat Genet
2021
53(6):869-880
PubMed ID: 33958780
DOI: 10.1038/s41588-021-00861-8
|
16060
Vinjamur DS, Yao Q, Cole MA, McGuckin C, Ren C, Zeng J, Hossain M, Luk K, Wolfe SA, Pinello L, Bauer DE.
ZNF410 represses fetal globin by singular control of CHD4
Nat Genet
2021
53(5):719-728
PubMed ID: 33859416
DOI: 10.1038/s41588-021-00843-w
|
16062
Demers M, Sturtevant S, Guertin KR, Gupta D, Desai K, Vieira BF, Li W, Hicks A, Ismail A, Gonçalves BP, Di Caprio G, Schonbrun E, Hansen S, Musayev FN, Safo MK, Wood DK, Higgins JM, Light DR.
MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell disease
Blood Adv . 2021
2021
1388-1402
PubMed ID: 33661300
DOI: 10.1182/bloodadvances.2020003670
|
16065
Baik R, Wyman SK, Kabir S, Corn JE.
Genome editing to model and reverse a prevalent mutation associated with myeloproliferative neoplasms
PLoS One
2021
16(3):e0247858
PubMed ID: 33661998
DOI: 10.1371/journal.pone.0247858
|
16892
Uchida N, Drysdale CM, Nassehi T, Gamer J, Yapundich M, DiNicola J, Shibata Y, Hinds M, Gudmundsdottir B, Haro-Mora JJ, Demirci S, Tisdale JF.
Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease
Mol Ther Methods Clin Dev
2021
21:121-132
PubMed ID: 33816645
DOI: 10.1016/j.omtm.2021.02.022
|
16895
Hua P, Badat M, Hanssen LLP, Hentges LD, Crump N, Downes DJ, Jeziorska DM, Oudelaar AM, Schwessinger R, Taylor S, Milne TA, Hughes JR, Higgs DR, Davies JOJ.
Defining genome architecture at base-pair resolution
Nature
2021
595(7865):125-129
PubMed ID: 34108683
DOI: 10.1038/s41586-021-03639-4
|
18386
Kevin R. Gillinder, Casie Leigh Reed, Shezlie Malelang, Helen Lorraine Mitchell, Emma Hoskin, Graham William Magor, Zane Kaplan, Andrew Charles Perkins
Gene Editing of KLF1 to Cure Sickle Cell Disease
Blood
2020
136:30-31
DOI: 10.1182/blood-2020-142339
|
18387
Divya S Vinjamur, Qiuming Yao, Mitchel A. Cole, Connor McGuckin, Chunyan Ren, Jing Zeng, Mir Hossain, Luca Pinello, Daniel E Bauer
ZNF410 Represses Fetal Globin By Devoted Control of CHD4/NuRD
Blood
2020
136:1-1
DOI: 10.1182/blood-2020-142134
|
18394
Georgia L. Gregory, Beeke Wienert, Marisa Schwab, Billie Rachael Lianoglou, Roger P. Hollis, Donald B. Kohn, Bruce R. Conklin, Tippi C. MacKenzie
Investigating Zeta Globin Gene Expression to Develop a Potential Therapy for Alpha Thalassemia Major
Blood
2020
136:3-4
DOI: 10.1182/blood-2020-142922
|
18429
Her NG, Babic I, Yenugonda VM, Kesari S, Nurmemmedov E.
Cellular thermal shift analysis for interrogation of CRISPR-assisted proteomic changes
Biotechniques
2020
68(4):180-184.
PubMed ID: 32040335
DOI: 10.2144/btn-2019-0100
|
18432
Zhang X, Chen L, Zhu B, Wang L, Chen C, Hong M, Huang Y, Li H, Han H, Cai B, Yu W, Yin S, Yang L, Yang Z, Liu M, Zhang Y, Mao Z, Wu Y, Liu M, Li D.
Increasing the efficiency and targeting range of cytidine base editors through fusion of a single-stranded DNA-binding protein domain
Nat Cell Biol
2020
22(6):740-750
PubMed ID: 32393889
DOI: 10.1038/s41556-020-0518-8
|
18433
Pavani G, Laurent M, Fabiano A, Cantelli E, Sakkal A, Corre G, Lenting PJ, Concordet JP, Toueille M, Miccio A, Amendola M.
Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins
Nat Commun
2020
11(1):3778
PubMed ID: 32728076
DOI: 10.1038/s41467-020-17552-3
|
18448
Jiang F, Zuo L, Li D, Li J, Tang X, Chen G, Zhou J, Lu H, Liao C.
Molecular epidemiology and hematologic characterization of δβ-thalassemia and hereditary persistence of fetal hemoglobin in 125,661 families of greater Guangzhou area, the metropolis of southern China
BMC Med Genet
2020
21(1):43
PubMed ID: 32111191
DOI: 10.1186/s12881-020-0981-x
|
18490
Boontanrart MY, Schröder MS, Stehli GM, Banović M, Wyman SK, Lew RJ, Bordi M, Gowen BG, DeWitt MA, Corn JE.
ATF4 Regulates MYB to Increase γ-Globin in Response to Loss of β-Globin
Cell Rep
2020
32(5):107993
PubMed ID: 32755585
DOI: 10.1016/j.celrep.2020.107993
|
18493
Karayel Ö, Xu P, Bludau I, Velan Bhoopalan S, Yao Y, Ana Rita FC, Santos A, Schulman BA, Alpi AF, Weiss MJ, Mann M.
Integrative proteomics reveals principles of dynamic phosphosignaling networks in human erythropoiesis
Mol Syst Biol
2020
16(12):e9813
PubMed ID: 33259127
DOI: 10.15252/msb.20209813
|
18505
Romano O, Petiti L, Felix T, Meneghini V, Portafax M, Antoniani C, Amendola M, Bicciato S, Peano C, Miccio A.
GATA Factor-Mediated Gene Regulation in Human Erythropoiesis
iScience
2020
23(4):101018
PubMed ID: 32283524
DOI: 10.1016/j.isci.2020.101018
|
6780
Makino T, Haruyama M, Katayama K, Terashima H, Tsunemi T, Miyazaki K, Terakawa M, Yamashiro K, Yoshioka R, Maeda H.
Phenotypic-screening generates active novel fetal globin-inducers that downregulate Bcl11a in a monkey model.
Biochem Pharmacol
2020
171:113717
PubMed ID: 31751536
DOI: 10.1016/j.bcp.2019.113717
|
8970
Leslie Weber, Giacomo Frati, Tristan Felix, Giulia Hardouin, Antonio Casini, Clara Wollenschlaeger, Vasco Meneghini, Cecile Masson, Anne De Cian, Anne Chalumeau, Fulvio Mavilio, Mario Amendola, Isabelle Andre-Schmutz, Anna Cereseto, Wassim El Nemer, Jean-Paul Concordet, Carine Giovannangeli, Marina Cavazzana, Annarita Miccio
Editing a γ-Globin Repressor Binding Site Restores Fetal Hemoglobin Synthesis and Corrects the Sickle Cell Disease Phenotype
Sci Adv
2020
6 (7), eaay9392
PubMed ID: 32917636
DOI: 10.1126/sciadv.aay9392
|
14505
Demirci S, Gudmundsdottir B, Li Q, Haro-Mora JJ, Nassehi T, Drysdale C, Yapundich M, Gamer J, Seifuddin F, Tisdale JF, Uchida N.
βT87Q-Globin Gene Therapy Reduces Sickle Hemoglobin Production, Allowing for Ex Vivo Anti-sickling Activity in Human Erythroid Cells
Mol Ther Methods Clin Dev
2020
17:912-921.
PubMed ID: 32405513
DOI: 10.1016/j.omtm.2020.04.013
|
18405
Kumkhaek C, LaChance C, Aerbajinai W, Zhu J, Rodgers GP.
Role of MFHAS1 in regulating hepcidin expression via the BMP/SMAD and MAPK/ERK1/2 signalling pathways
Br J Haematol
2019
186(4):e108-e112
PubMed ID: 31049940
DOI: 10.1111/bjh.15939
|
18411
Lan X, Khandros E, Huang P, Peslak SA, Bhardwaj SK, Grevet JD, Abdulmalik O, Wang H, Keller CA, Giardine B, Baeza J, Duffner ER, El Demerdash O, Wu XS, Vakoc CR, Garcia BA, Hardison RC, Shi J, Blobel GA.
The E3 ligase adaptor molecule SPOP regulates fetal hemoglobin levels in adult erythroid cells
Blood ABlood Adv
2019
3(10):1586-1597.
PubMed ID: 31126914
DOI: 10.1182/bloodadvances.2019032318
|
18427
Rivers A, Molokie R, Lavelle D.
A new target for fetal hemoglobin reactivation
Haematologica
2019
104(12):2325-2327
PubMed ID: 31787612
DOI: 10.3324/haematol.2019.230904
|
6745
Hyle J, Zhang Y, Wright S, Xu B, Shao Y, Easton J, Tian L, Feng R, Xu P, Li C.
Acute depletion of CTCF directly affects MYC regulation through loss of enhancer-promoter looping.
Nucleic Acids Res
2019
47(13):6699-6713
PubMed ID: 31127282
DOI: 10.1093/nar/gkz462
|
6766
Mudit Chaand, PhD , Chris Fiore, PhD , Brian T Johnston, MS , Diane H Moon, PhD , John P Carulli, PhD , Jeffrey R Shearstone, PhD
Chromatin Accessibility Mapping of Primary Erythroid Cell Populations Leads to Identification and Validation of Nuclear Factor I X (NFIX) As a Novel Fetal Hemoglobin (HbF) Repressor
Blood
2019
134 (Supplement_1): 812
DOI: 10.1182/blood-2019-124337
|
6767
Laura Breda, PhD , Valentina Ghiaccio, PhD , Silvia Pires Lourenco, MSc , Danuta Jadwiga Jarocha, PhD , Yasuhiro Ikawa, MD PhD , Naoto Tanaka, PhD , Virginia Guzikowski , Carla Casu, PhD , Kim Smith-Whitley, MD , Janet L. Kwiatkowski, MD MSCE , Stefano Rivella, PhD
Preclinical Evaluation of ALS20, a New and Improved Lentiviral Vector for Beta-Globinopathies
Blood
2019
134 (Supplement_1): 2242
DOI: 10.1182/blood-2019-124043
|
6769
Craig M Forester, MD PhD , Gun Woo-Byeon , Juan Oses-Prieto, PhD , Al Burlingame, PhD , Maria Barna, PhD , Davide M Ruggero, PhD
Regulation of eIF4E Guides a Unique Translational Program to Steer Erythroid Maturation
Blood
2019
134 (Supplement_1): 156
DOI: 10.1182/blood-2019-129608
|
6772
Kang J, Kang Y, Kim YW, You J, Kang J, Kim A.
LRF acts as an activator and repressor of the human β-like globin gene transcription in a developmental stage dependent manner.
Biochem Cell Biol
2019
97(4):380-386
PubMed ID: 30427207
DOI: 10.1139/bcb-2018-0303
|
6779
Sukanya Chumchuen, MSc, BSc , Tanapat Pornsukjantra, B.Sc. , Pinyaphat Khamphikham, PhD , Usanarat Anurathapan, MD , Orapan Sripichai, PhD
Downregulation of Transcription Factor LRF/ZBTB7A Increases Fetal Hemoglobin Expression in β-Thalassemia/Hemoglobin E Erythroid Cells
Blood
2019
134 (Supplement_1): 3549
DOI: 10.1182/blood-2019-126664
|
6783
Pamela Himadewi, BSc , Xiaotian Zhang, PhDBS , Haley Gore, MS , Xue Qing David Wang, PhD
Chromosomal Loop Editing Reveals New Epigenomic Landscape in the β-Globin Locus with Implications for Hemoglobinopathy Therapies
Blood
2019
134 (Supplement_1): 813
DOI: 10.1182/blood-2019-125020
|
6792
Zhou Z, Giles KE, Felsenfeld G.
DNA·RNA triple helix formation can function as a cis-acting regulatory mechanism at the human β-globin locus.
Proc Natl Acad Sci U S A
2019
116(13):6130-6139
PubMed ID: 30867287
DOI: 10.1073/pnas.1900107116
|
6794
Li C, Mishra AS, Gil S, Wang M, Georgakopoulou A, Papayannopoulou T, Hawkins RD, Lieber A.
Targeted Integration and High-Level Transgene Expression in AAVS1 Transgenic Mice after In Vivo HSC Transduction with HDAd5/35++ Vectors.
Mol Ther
2019
27(12):2195-2212
PubMed ID: 31494053
DOI: 10.1016/j.ymthe.2019.08.006
|
6797
Wang H, Liu Z, Li C, Gil S, Papayannopoulou T, Doering CB, Lieber A
High-level protein production in erythroid cells derived from in vivo transduced hematopoietic stem cells.
Blood Adv
2019
3(19):2883-2894
PubMed ID: 31585952
DOI: 10.1182/bloodadvances.2019000706
|
6801
Ludwig LS, Lareau CA, Bao EL, Nandakumar SK, Muus C, Ulirsch JC, Chowdhary K, Buenrostro JD, Mohandas N, An X, Aryee MJ, Regev A, Sankaran VG.
Transcriptional States and Chromatin Accessibility Underlying Human Erythropoiesis.
Cell Rep
2019
27(11):3228-3240.e7
PubMed ID: 31189107
DOI: 10.1016/j.celrep.2019.05.046
|
6810
Métais JY, Doerfler PA, Mayuranathan T, Bauer DE, Fowler SC, Hsieh MM, Katta V, Keriwala S, Lazzarotto CR, Luk K, Neel MD, Perry SS, Peters ST, Porter SN, Ryu BY, Sharma A, Shea D, Tisdale JF, Uchida N, Wolfe SA, Woodard KJ, Wu Y, Yao Y, Zeng J, Pruett-Miller S, Tsai SQ, Weiss MJ.
Genome editing of HBG1 and HBG2 to induce fetal hemoglobin.
Blood Adv
2019
3(21):3379-3392
PubMed ID: 31698466
DOI: 10.1182/bloodadvances.2019000820
|
6816
Papasavva P, Kleanthous M, Lederer CW.
Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases.
Mol Diagn Ther.
2019
23(2):201-222
PubMed ID: 30945166
DOI: 10.1007/s40291-019-00392-3
|
18193
Alicia Chang, So Hyun Park, Ciaran M Lee, Alireza Paikari, Gang Bao, Vivien A Sheehan
Sickle Human Umbilical Cord Derived Erythroid Progenitor Cells (S-HUDEP2): An Ideal in-Vitro System for Screening Anti-Sickling Compounds for Sickle Cell Disease
Blood
2018
132:3675-3675
DOI: 10.1182/blood-2018-99-117158
|
18395
Peng Xu, Daniel C. Scott, Xing Tang, Yu Yao, Yong-Dong Wang, Wenjian Bi, Lance E. Palmer, Ruopeng Feng, Arno F. Alpi, Chunliang Li, Yong Cheng, Brenda A. Schulman, Mitchell J. Weiss
FBXO11 Activates Erythroid Gene Transcription By Degrading Heterochromatin-Associated Protein BAHD1
Blood
2018
132:529-529
DOI: 10.1182/blood-2018-99-117362
|
18397
Ruopeng Feng, Phillip A Doerfler, Yu Yao, Xing Tang, Yong-Dong Wang, Chunliang Li, David E. Root, Yong Cheng, Mitchell J. Weiss
The DNA Methylation Maintenance Protein UHRF1 Regulates Fetal Globin Expression Independent of HBG Promoter DNA Methylation
Blood
2018
132:410-410
DOI: 10.1182/blood-2018-99-115589
|
18407
Peter Balogh, Brian Capaldo, Sandeep Singh, Kamaleldin Elagib, Hui Li, Eli Zunder, Maria E. Figueroa, Wendy Pang, Adam Goldfarb
Dysregulation of RUNX3 in Aged Human HSPCs May Contribute to Perturbations in Erythropoiesis and Balanced Lineage Output
Blood
2018
132:2553-2553
DOI: 10.1182/blood-2018-99-115245
|
18496
Li C, Psatha N, Sova P, Gil S, Wang H, Kim J, Kulkarni C, Valensisi C, Hawkins RD, Stamatoyannopoulos G, Lieber A.
Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing
Blood
2018
131(26):2915-2928
PubMed ID: 29789357
DOI: 10.1182/blood-2018-03-838540
|
18510
Xianjiang Lan, Eugene Khandros, Jeremy D. Grevet, Scott A. Peslak, Saurabh Bhardwaj, Cheryl A. Keller, Belinda Giardine, Ben A. Garcia, Ross C. Hardison, Junwei Shi, Gerd A. Blobel
Domain-Focused CRISPR-Cas9 Screen Identifies the E3 Ubiquitin Ligase Substrate Adaptor Protein SPOP as a Novel Repressor of Fetal Hemoglobin
Blood
2018
132:414-414
DOI: 10.1182/blood-2018-99-119518
|
4246
Schoonenberg VAC, Cole MA, Yao Q, Macias-Treviño C, Sher F, Schupp PG, Canver MC, Maeda T, Pinello L, Bauer DE.
CRISPRO: identification of functional protein coding sequences based on genome editing dense mutagenesis.
Genome Biol.
2018
PubMed ID: 30340514
DOI: 10.1186/s13059-018-1563-5
|
4518
Vinjamur DS, Bauer DE
Growing and Genetically Manipulating Human Umbilical Cord Blood-Derived Erythroid Progenitor (HUDEP) Cell Lines.
Erythropoiesis
2018
275-284
PubMed ID: 29076097
DOI: 10.1007/978-1-4939-7428-3_17
|
6782
Li C, Psatha N, Gil S, Wang H, Papayannopoulou T, Lieber A.
HDAd5/35++ Adenovirus Vector Expressing Anti-CRISPR Peptides Decreases CRISPR/Cas9 Toxicity in Human Hematopoietic Stem Cells.
Mol Ther Methods Clin Dev
2018
9:390-401
PubMed ID: 30038942
DOI: 10.1016/j.omtm.2018.04.008
|
6805
Nussbaum L, Telenius JM, Hill S, Hirschfeld PP, Suciu MC, WIGWAM Consortium, Downes DJ, Hughes JR.
High-Throughput Genotyping of CRISPR/Cas Edited Cells in 96-Well Plates.
Methods Protoc
2018
1(3):29
PubMed ID: 31164571
DOI: 10.3390/mps1030029
|
6806
Hsu JY, Fulco CP, Cole MA, Canver MC, Pellin D, Sher F, Farouni R, Clement K, Guo JA, Biasco L, Orkin SH, Engreitz JM, Lander ES, Joung JK, Bauer DE, Pinello L.
CRISPR-SURF: discovering regulatory elements by deconvolution of CRISPR tiling screen data.
Nat Methods
2018
15(12):992-993
PubMed ID: 30504875
DOI: 10.1038/s41592-018-0225-6
|
6812
Leung A, Zulick E, Skvir N, Vanuytsel K, Morrison TA, Naing ZH, Wang Z, Dai Y, Chui DHK, Steinberg MH, Sherr DH, Murphy GJ.
Notch and Aryl Hydrocarbon Receptor Signaling Impact Definitive Hematopoiesis from Human Pluripotent Stem Cells.
Stem Cells
2018
36(7):1004-1019
PubMed ID: 29569827
DOI: 10.1002/stem.2822
|
6822
Canver MC, Haeussler M, Bauer DE, Orkin SH, Sanjana NE, Shalem O, Yuan GC, Zhang F, Concordet JP, Pinello L
Integrated design, execution, and analysis of arrayed and pooled CRISPR genome-editing experiments.
Nat Protoc
2018
13(5):946-986
PubMed ID: 29651054
DOI: 10.1038/nprot.2018.005
|
18392
Xiaofei Yu, Alex Azzo, David C. Williams, Gordon Ginder
MBD2-NuRD but Not MBD3-NuRD Mediates Strong Silencing of Fetal γ-Globin Gene Expression in Human Adult Erythroid Cells
blood
2017
130:2220
DOI: 10.1182/blood.V130.Suppl_1.2220.2220
|
18404
Naoya Uchid, Anna Shvygin, Lydia Raines, Juan Jesus J. Haro Mora, Selami Demirci, Matthew M. Hsieh, John F Tisdale
Selective Proliferation of Gene-Modified Human Erythroid Cells with Truncated Erythropoietin Receptors
Blood
2017
130:3338
DOI: 10.1182/blood.V130.Suppl_1.3338.3338
|
6781
Maroofi N, Azarkeivan A, Banihashemi S, Mohammadparast S, Aghajanirefah A, Banan M.
An enhancer haplotype may influence BCL11A expression levels and the response to hydroxyurea in β-thalassemia patients.
Pharmacogenomics
2017
18(10):995-967
PubMed ID: 28639471
DOI: 10.2217/pgs-2017-0019
|
6800
Joung J, Konermann S, Gootenberg JS, Abudayyeh OO, Platt RJ, Brigham MD, Sanjana NE, Zhang F.
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening.
Nat Protoc
2017
12(4):828-863
PubMed ID: 28333914
DOI: 10.1038/nprot.2017.016
|
18412
Emily N Stern, Samuel Lessard, Patrick G. Schupp, Falak Sher, Guillaume Lettre, Daniel E. Bauer
An Essential Erythroid-Specific Enhancer of ATP2B4 Associated with Red Blood Cell Traits and Malaria Susceptibility
Blood
2016
128:1250-1250
DOI: 10.1182/blood.V128.22.1250.1250
|